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Abstract 
Three synthetic peptides corresponding to transmembrane segments TMS1, TMS3 
and TMS6 of secondary-active transporter MntH from Escherichia coli were used 
as a suitable alternative model enabling to study TMS structure, TMS interaction with 
membranes, TMS mutual interaction and also function of MntH. The secondary structure 
of the peptides was estimated in different environments using circular dichroism 
spectroscopy. These peptides interacted with and adopted helical conformation in lipid 
membranes. Electrophysiological experiments demonstrated that individual TMS were able 
under certain conditions to form ion channels in model biological membranes. 
Electrophysiological properties of these weakly cation-selective ion channels were strongly 
dependent on surrounding pH. Manganese ion, as a physiological substrate of MntH, 
enhanced the conductivity of TMS1 and TMS6 channels, influenced the transition between 
closed and open states and affected the conformation of all studied peptides. For TMS3 
Mn
2+
 was crucial for formation of ion channels. It was shown that a single functionally 
important TMS can retain some of the functional properties of the full-length protein. 
These findings can contribute to understanding of structure-function relationship 
at the molecular level. However, it remains unclear to what extent the peptide-specific 
channel activity represents a functional aspect of the full-length membrane carrier protein. 
Keywords: divalent metal ions, membrane transport, MntH, Nramp, patch clamp, 
CD spectroscopy 
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Abstrakt 
Syntetické peptidy odpovídající svojí sekvencí transmembránovým segmentům 
TMS1, TMS3 a TMS6 sekundárně aktivního transportního proteinu MntH z bakterie 
Escherichia coli byly použity jako model pro studium struktury, interakce s modelovými 
membránami, vzájemné interakce TM segmentů a jejich funkce. Sekundární struktura byla 
pomocí spektroskopie cirkulárního dichroismu určována v různých prostředích. Studované 
peptidy interagovaly s lipidovou membránou a získávaly v tomto prostředí helikální 
konformaci. Elektrofyziologické experimenty dokázaly, že samostatné TMS jsou schopny 
za určitých podmínek tvořit iontové kanály v modelových biologických membránách. 
Elektrofyziologické vlastnosti těchto slabě kationtově selektivních kanálů jsou silně závislé 
na pH okolního prostředí. Mangan, jako fyziologický substrát MntH, zvýšil vodivost 
kanálů tvořených TMS1 a TMS6 a ovlivnil přechod mezi zavřeným a otevřeným stavem 
kanálu. Byl pozorován vliv manganu na konformaci všech studovaných peptidů. V případě 
TMS3 byla přítomnost Mn2+ pro tvorbu iontových kanálů dokonce nezbytná. Bylo 
dokázáno, že kanál tvořený funkčně důležitým TMS může do určité míry zachovat funkční 
vlastnosti celého proteinu. Tyto výsledky mohou přispět k porozumění vztahu mezi 
strukturou a funkcí na molekulární úrovni. I přesto však zůstává nejasné, do jaké míry 
peptidově specifická kanálová aktivita reprezentuje funkční aspekt celého membránového 
trasnportního proteinu. 
Klíčová slova: dvojmocné kovové ionty, membránový transport, MntH, Nramp, 
patch clamp, CD spektroskopie 
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1. General Introduction 
The focus of this study is on one bacterial member of the Nramp (Natural resistance-
associated macrophage protein) family – MntH (Proton-dependent manganese 
transporter) from Escherichia coli (E. coli). The Nramp family is a group of secondary 
active divalent metal ion transporters, conserved throughout the evolution, playing an 
important role in biological processes [1-3]. So far, most information about this divalent 
metal ion/proton symporter was obtained using the whole-cell model system. Due 
to the difficulties with experimental procedures involved in membrane protein isolation 
purification and reconstitution, another possible approach was needed. As an alternative 
to this approach, synthetic peptides corresponding to transmembrane segments (TMS) were 
used as a model system. Three essential transmembrane segments of the secondary-active 
transporter were studied, focusing on the possible role of these domains in the structure and 
function of a full-length MntH. These segments contain important residues and 
understanding of their structural and functional properties could be essential for 
understanding of the structure-function relationship of the transporter. 
This introduction gives a brief overview on general membrane transport principles, 
followed by the explanation of the transport of metal ions, and thereafter the Nramp family 
is introduced. At the end of the chapter the details about the experimental approach using 
transmembrane peptides as a model system are explained. 
1.1 Membrane transport 
In general, the passage of solutes across membranes can occur via protein-independent 
diffusion or protein-dependent transport processes. Protein-dependent transport includes 
transport via carriers or channels [4]. Channel proteins form small hydrophilic pores in 
the membrane, through which solutes can pass. The solutes still follow their concentration 
gradient without requirement of energy. This transport, due to its similarity to diffusion, is 
called “facilitated diffusion”. On the other hand, carriers bind the solute on one side and 
deliver it to the other side of the membrane, through a change of conformation of 
the carrier protein. Carrier binds the solute with great specificity, it is this requirement for 
specific binding which makes the transport selective. Transport can also occur against 
a concentration gradient and consequently requires energy. Mostly the solutes transported 
in this way are either small organic molecule or inorganic ions. 
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In contrast to primary active transport (driven by ATP hydrolysis), the secondary active 
transport is not directly coupled with ATP hydrolysis. The chemical coupling uses the free 
energy produced by the electrochemical potential of another solute. Pre-existing gradients 
which are maintained by the action of primary systems are used as driving forces. 
The solutes can be transported in several different ways. Some of the carriers transport 
a single solute across the membrane (uniport). Coupled transport, where the transport of 
one solute strictly depends on the transport of the second, involves either the simultaneous 
transfer of the second solute in the same direction (symport as for example with MntH 
the symport of metal ions and protons, see Fig. 1.1) or the transfer of a second solute in 
the opposite direction (antiport) [4]. 
 
Figure 1.1: Coupled transport of solutes [4] 
Membrane transport proteins belong to the group of integral membrane proteins able to 
span the entire phospholipid bilayer. Most integral proteins contain residues with 
hydrophobic side chains. These interact with fatty acyl groups of the membrane 
phospholipids, thus anchoring the protein to the membrane. In the most common case, 
the membrane spanning domains of integral proteins are α-helices or possibly multiple β-
strands forming β-barrel structure within the membrane [5]. 
1.2 Metal ion transport 
Metal ions are important for all living cells and participate in numerous metabolic 
junctions as cofactors of many enzymes, gene regulation, oxidative phosphorylation, free-
radical homeostasis and signal transduction pathways [1,6]. There are several transport 
systems maintaining the homeostasis of metal ions. A high level of regulation is crucial 
because limited activity of a single metal ion transporter may inhibit cell growth due to 
the shortage of a vital metabolic element, and excess transporter activity may be toxic and 
lead to cell death [6]. In some of the cellular organelles and the plasma membrane, high 
14 
 
and low affinity transporters act in concert to maintain the right balance of metal ion 
concentrations [7-9]. 
 
 
Figure 1.2 Periodic table of the metal elements [10]. The f-block elements (lanthanides and actinides) are 
not shown. The group of the d-block/transition elements is highlighted by a square. Most “trace elements” are 
found within this group (boxed). Bulk essential elements are circled. The black line is the border between 
metallic elements (on the left) and non-metals (on the right). This border is not strict, since the elements near 
it do not possess features strictly metallic or non-metallic, respectively. It is noteworthy that the elements 
essential for life are the lighter elements, which are also most abundant on earth [10]. 
 
Metal ion homeostasis is maintained through highly regulated processes of uptake, 
storage and secretion. Homeostasis of metal ions is governed by two evolutionary 
consequences (i) redox reactions are fundamental life processes and transition metals are 
essential for the function of most proteins involved in redox reactions, hence living cells 
compete for metal ion resources; (ii) The development of several life processes involves 
toxic reagents that, when present in abnormal amounts, cause damage to the very function 
that they serve and to proteins and nucleic acids that are present in their proximity. For 
example the mammalian brain utilizes components such as NO, CO and metal ions that 
inflict damage during their normal physiological action [6,11]. 
Essential elements such as copper, manganese, iron or zinc, which belong to the group 
of transition metals, are only needed in trace amounts (Fig 1.2). However, this does not 
derogate their importance [10]. Manganese ion
 
is necessary to both free-living and 
d-block/ transition elements 
p-block elements 
s-block 
elements 
metals             non-metals 
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pathogenic bacterial cells for nutrient and defense purposes [12,13]. This redox active
 
metal is a key cofactor for a wide range of metalloenzymes,
 
including oxidases and 
dehydrogenases, DNA and RNA polymerases,
 
kinases, decarboxylases, and sugar 
transferases [14]. It is mainly known to be involved in the oxygen production in the oxygen 
evolving complex in photosystem II and for its action in the dismutation of the superoxide 
anion as a cofactor in MnSOD (manganese superoxide dismutase). Mn
2+ 
can function in 
place of Mg
2+ 
in a variety of both structural and catalytic roles [15]. Despite its role as 
a nutrient it can be also toxic. In humans manganese toxicity is recognized to be a serious 
health hazard resulting in severe pathologies of the central nervous system. If the exposure 
occurs for a long period of time, the toxicity can result in a permanent crippling of 
the extrapyramidal system, with symptoms reminiscent of Parkinson disease [16]. 
The cellular requirements for manganese (submicromolar levels) are generally much lower 
than for iron [17]. Iron, which is symported with protons by Nramp2 [18], is an essential 
component of hemoglobin, cytochromes and variety of other enzymes. Together with 
copper, they are cofactors of a large number of metalloproteins catalyzing redox reactions. 
Furthemore, zinc is essential for the formation of the “zinc-finger”, a structural element in 
proteins important for the functionality of transcription factors in transcriptional regulation. 
It is also a cofactor of enzymes involved in the synthesis of nucleic and amino acids [19]. 
A number of uptake mechanisms for micronutrients such as metal ions have evolved 
and many of them have been characterized in prokaryotes and eukaryotes. Metal ion 
transporters provide an efficient tool for competition for the limited resources, and at 
the same time their regulation should provide solution to the changing environment and 
the potential damage inflicted by abnormal concentrations. The calcium homeostasis is 
maintained by the coordination transport system, like Ca
2+
 ATPases [20,21,22], Na
+
/Ca
2+
 
[23,24] and H
+
/Ca
2+
 exchangers [25,26] and several other transport systems. Iron uptake to 
mammalian cells involves receptor-mediated endocytosis [27]. Other important metal ions, 
which are essential for the life cycle of eukaryotic cells like Mn
2+
 and Zn
2+
 are transported 
by several families of transporters like CDF family (cation diffusion facilitator proteins) 
identified in bacteria, archaea and eukaryotes (reviewed in [28]), CPx-type ATPases 
(including P-type ATPases) transporting metal ions across the membrane [29] or ZIP 
family. ZIP stands for Zrt, Irt-like protein. Zrt1 (zinc regulated transporter 1) is an 
S. cerevisiae zinc transporter [30]; Irt1 (iron regulated transporter 1) functions as an iron 
transporter in Arabidopsis thaliana [31]. The ZIP family includes members from plants, 
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protozoa, insects, mammals and fungi, as well as from eubacteria and archaea [32]. 
Another important family participating in divalent metal ion homeostasis is the Nramp 
family briefly introduced in the next section. 
 
Figure 1.3 Metal symport of a member of Nramp family 
1.3 The Nramp family 
The Nramp family of secondary active divalent metal ion membrane transport proteins 
plays an important role in a variety of biological processes include metal ion homeostasis 
[1-3] and innate immunity [33,34]. This family has been highly conserved throughout 
evolution. Members of the Nramp family share remarkable protein sequence identity: yeast 
(28%), plant (40%), and fly (55%) with sequence identity to the mammalian proteins 
(46%, 58%, and 73% similarity, respectively) [35]. The Nramp proteins are electrogenic 
divalent metal ion/proton symporters with broad specificity for d- block transition metals, 
including manganese, iron, cobalt, cadmium, zinc, copper and nickel (Fig. 1.3) 
[1,34,36,37]. It consists of five phylogenetic groups – three bacterial groups (MntH A, 
MntH B and MntH C) and two eukaryotic groups (prototypical and archetypical group). 
The existence of bacterial Nramp homologs suggests that the Nramp family originated in 
prokaryotes [3,38]. 
Nramp proteins are present in eukaryotes, but also in yeast (Smf proteins) [39] and 
bacteria [36]. Except for yeast homologs, eukaryotic Nramp proteins are composed of 
twelve TMS (transmembrane segments) [37,39,40], whereas bacterial MntH transporters 
are integral transmembrane proteins predominantly with eleven TMS (Fig. 1.4). 
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1.3.1 Nramp1 (SLC11A1) 
Nramp1 has been identified in the mouse Bcg/Ity/Lsh locus by positional cloning [41]. 
It was found to be identical to the Ity and the Lsh gene conferring resistance to infections 
by Salmonella typhimurium and Leishmania donovani, respectively [42].  Nramp1 is 
expressed in lysosomal compartment of macrophages and neutrophils and recruited to 
the membrane of the pathogen-containing phagosomes upon phagocythosis [43-45]. It was 
proposed that Nramp1 encodes an integral membrane protein that has structural homology 
with known prokaryotic and eukaryotic transport systems [46]. 
This transporter is, due to its exclusivity in metal transport (Fe
2+
, Mn
2+ 
and Co
2+
) across 
the phagosomal membrane of macrophages, necessary for the defense against bacterial 
infection [33,47]. In humans, polymorphic variants at Nramp1 are associated with 
increased susceptibility to tuberculosis and leprosy [48,49]. 
1.3.2 Nramp2 (DMT1, DCT1, SLC11A2) 
The second member of the Nramp family, Nramp2 was identified as a gene expressed 
in the duodenum of rats and capable of transporting divalent metal ions with an unusually 
broad substrate specificity (including Mn
2+
, Zn
2+
, Co
2+
, Cd
2+
, Cu
2+
, Ni
2+ 
and Pb
2+
) [1]. 
Nramp2 plays several important roles in iron metabolism. It mediates metal ion transport 
which is H
+
-coupled and voltage dependent. It is driven by the H
+ 
electrochemical potential 
gradient. As opposed to Nramp1, which is expressed exclusively in mononuclear 
phagocytes such as tissue macrophages [46], Nramp2 mRNA expression is more 
ubiquitous and has been detected in most tissues and cell type’s analyzed [1,50,51]. 
However, its levels of expression are higher in the brain, thymus, proximal intestine, 
kidney, and bone marrow [1]. The overall identity with Nramp1 is 64%, identity of 
mammal Nramp2 to Nramp1 over the hydrophobic core is 78% [43]. Genetic studies in rat 
and mouse models revealed that Nramp2 is unconditionally required for the maintenance 
of life. Mutations in Nramp2 affect iron homeostasis, and cause defects in intestinal iron 
uptake resulting in severe iron disorders (microcytic anemia and serum and hepatic 
overload) [52]. Nramp2 deficient rats also show marked Mn
2+ 
deficiency [53]. Study 
focusing on the localization of human Nramp2 showed that the protein colocalizes with 
markers for late endosomes/lysosomes but not with the transferrin receptor (TfR, which is 
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a marker for sorting and recycling endosomes and the plasma membrane) in non-intestinal 
cells [54]. After these results it was suggested that Nramp2 is involved in the distribution 
of iron in non-intestinal cells as well as in absorption of intestinal iron. Three pathways 
have been proposed in which Nramp2 may play a role: i) nutritional iron absorption in 
enterocytes, ii) recycling of iron from phagocytosed erythrocytes, and/or iii) transferrin-
dependent iron uptake in erythrocytes and other cells [54]. 
1.3.3 Smf 
There are three functionally distinct forms of the Nramp transporters in yeast – Smf1p, 
Smf2p, and Smf3p. They have been identified and characterized in Saccharomyces 
cerevisiae. [34,39]. These three transport proteins operate in distinct cellular compartments 
to differentially affect the transport and intracellular trafficking of iron and manganese ions 
and to lesser extent cobalt and copper [55]. Smf1p is a proton coupled metal transporter 
capable of translocating a wide range of divalent heavy metals, expressed on the cell 
surface. The proposed physiological function of Smf1p is to contribute to manganese 
uptake when cells are starved for this metal e.g., by depleting manganese with EGTA [55]. 
Smf1p together with Smf2p were shown to mediate Fe 
2+
 uptake into Xenopus laevis 
oocytes [56] and contribute to copper and cadmium accumulation. Smf2p can
 
affect cobalt 
levels in yeast [57] and may also participate
 
in manganese trafficking [58]. Smf3p 
participate in iron metabolism in yeast as well. The major role is in controlling the cellular 
iron ion levels. It mobilizes vacuolar stores of iron in conditions of low iron levels [39,59]. 
1.3.4 MntH 
MntH is a bacterial homolog of Nramp. It is a primary high-affinity Mn
2+
 transporter of 
Escherichia coli with a considerable homology to the eukaryotic Nramp proteins [60]. This 
homology to the eukaryotic family members and the fact that the Nramp family originated 
in prokaryotes (Cellier et al. 2001, Richer et al. 2003) makes MntH an attractive prototypic 
model of the Nramp family. Three bacterial groups MntH A-C differ in sequence (26-29 ± 
3% identical) and in site-specific evolutionary rates [61]. Bacterial MntH transporters are 
integral transmembrane proteins predominantly with 11 TMS (Fig. 1.4). The N–terminus 
of the protein is located in cytoplasm and its C–terminus is exposed to the periplasmic side 
of the membrane as confirmed for MntH of E. coli [62]. The influx system of MntH 
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mediates the influx of Mn
2+
 with an affinity of about 0.1 μM in Salmonella enterica ssp. 
typhimurium and of 0.5 μM in E. coli [15]. In accordance with broad metal specificity of 
eukaryotic Nramp proteins, MntH of E. coli is also able to transport Cd
2+
, Zn
2+
, Co
2+
, Fe
2+
 
and probably also Cu
2+
 and Ni
2+
 [36,63]. Fe
2+
 is transported with an affinity of > 10 μM, 
far higher than physiological concentrations of free Fe
2+
.  
 
Figure 1.4 Ecoli MntH consensus transmembrane topology [62] 
1.4 Transmembrane peptides 
So far, practically all experimental information about Nramp family was acquired using 
the whole-cell model systems [40]. Because of difficulties with experimental procedures 
involved in membrane protein isolation purification and reconstitution, another possible 
approach was needed. This approach was to what is sometimes referred as a “divide and 
conquer” approach to membrane protein [64]. The fundamental explanation is to divide an 
α-helical membrane protein into its constituent transmembrane domains, which can 
normally be produced more easily and investigated in a wider range of membrane-mimetic 
systems than their full-length parent protein [65]. Peptide folding and insertion into 
membrane are nowadays widely studied using this approach.  
Applicability of this approach is supported by the fact that, the folding of membrane 
proteins is considered as a four steps process, according to the current four-step 
thermodynamic model of membrane folding [66]. Previous hypothesis proposed three-step 
model [67], composed of interfacial partitioning, folding and insertion. A year later, two-
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stage hypothesis was proposed [68]. According to this model, at first hydrophobic peptide 
sequence form independently stable α-helical TM domains upon insertion into bilayer. In 
the second step, membrane embedded helices interact with each other to establish protein’s 
tertiary structure [65]. This hypothesis has found support from thermodynamic arguments 
[67-69] and also from protein fragmentation studies [70-73]. Four-step model was 
a combination of these two models [66].   
Due to the fact that transmembrane domains could be considered as independent, 
peptide folding and insertion can be studied on individual transmembrane segments. 
Utilizing simple functional domains of the full-length membrane proteins can lead to 
valuable insights into their structure-function relationship. Synthetic peptides 
corresponding to the TMS of membrane proteins have been previously used as alternative 
models for studying the structure and interaction of membrane proteins with biological 
membranes [74].  
TM peptides can be obtained by proteolytic cleavage of naturally occurring or 
recombinantly engineered proteins, like full-length glycophorin A (GpA) produced by 
tryptic fragmentation [70], or by means of chemical synthesis. This latter method, 
published by Galardy & Kortylewicz for the first time in 1985, is dominant nowadays 
thanks to advances in solid-phase peptide synthesis [75]. An alternative way of obtaining 
TM peptides is through biosynthesis in cell culture, especially in case of difficult chemical 
synthesis of exceptionally long or isotopically labeled peptides [65]. Several model 
systems for studying the secondary structure of TM peptides are available with their 
strength and weaknesses as summarized in the next subsection.  
1.4.1 Model systems for studying the secondary structure of TM peptides 
The majority of peptides corresponding to membrane-spanning regions are too 
hydrophobic to be soluble in aqueous solutions. TM peptides are usually largely unfolded 
and behave like random coils when dissolved as monomers in aqueous solutions [76,77]. 
A notable example of water-soluble TM peptide is TM helix 3 of bacteriorhodopsin. 
Engelman and coworkers synthesized and characterized seven peptides, corresponding to 
seven transmembrane domains of the full-length protein. Within these TMS the third TM 
helix is soluble in aqueous solutions in the absence of membrane-mimetic systems [78]. 
More often, isotropic solvents, such as TFE, as a simple membrane-mimetic system for 
peptides are used. Obvious advantages of isotropic solvents are the high solubilities of 
many TM peptides and the straightforward applicability of a broad spectrum of 
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experimental methods [65]. Molecular dynamics simulation suggest, that isotropic organic 
solvents such as DMSO [79] and TFE [80] induce peptide secondary structure by 
preferential clustering around the peptide and thus limiting water access to the peptide 
backbone. Formation of any type of secondary structure will be promoted by TFE as long 
as requirements for intramolecular hydrogen bonding are satisfied [65]. On the other hand, 
isotropic solvents usually disrupt the tertiary and quaternary contacts at high solvent 
concentrations, because their solvent shells impair such interactions. Thus, while organic 
solvents are frequently used in structural studies on single, monomeric peptides, they are 
widely considered unsuitable for investigations of helix-helix interactions and peptide 
oligomerization [65]. However, oligomers, composed of peptide corresponding to TM 
domain 4 of DMT1 and TMS4 of Nramp1, were discovered even in 100% TFE [81-84], 
using diffusion-ordered NMR spectroscopy. The helicity of TMS4 of Nramp1 in pure TFE 
was clearly dependent on peptide concentration. Even though isotropic solvents offer 
a good starting point for further investigations of TM peptide, the information gathered 
from organic isotropic solvents should be interpreted with caution when extrapolating to 
more complex systems [65]. 
Another system for studying membrane-interacting peptides is detergent micelles. 
Detergents are amphiphilic compounds, consisting like bilayer-forming lipids of bulkier 
hydrophilic headgroups and hydrophobic tail. This molecular shape impedes self-
association of peptides when the detergent concentration exceeds the critical micellar 
concentration (CMC). SDS as the most common representative of denaturing detergents 
has been suggested to directly bind to helix-helix interfaces by van der Waals forces, 
thereby inhibiting interhelical interactions [85]. However, micelles are still used for 
studying peptide oligomerization innumerous studies by Lemmon and co-workers and 
others [86-88]. One of these studies focused on oligomerization of TMS4 of DMT1 in SDS 
[81,82] as an extension of their studies in 100% TFE or 40% HFIP. 
Lipid vesicles are versatile model systems for studying TM peptides. Lipid bilayers 
offer an environment to peptides and proteins that more closely resembles natural 
membranes than do isotropic solvents or detergent micelles. Lipid vesicles were used to 
compare the dimeric structure of glycophorin A (GpA) TM domain with the corresponding 
structure in detergent micelles [89,90]. Although the differences in GpA dimer structure 
between micelles and vesicles are partially due to an insufficient number of distance 
constraints in the micellar system [90], three observations are worth mentioning: First, in 
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lipid bilayers, but not in micelles, glycine-glycine (G79, G83) contacts are obvious, which 
are abundant in helix–helix interfaces of membrane proteins [91,92]. Second, the bilayer-
embedded dimer is stabilized by an interhelical hydrogen bond (1T87↔2I88), which does 
not show up in the micelle-suspended dimer [89,93]. Third, the dimer structures obtained 
in DMPC and POPC bilayers are indistinguishable in spite of marked differences in 
hydrophobic bilayer thickness. Thus, although the dimer structures in micelles and bilayers 
share the same overall fold, they substantially differ in their structural details. By contrast, 
the choice of lipid constituting the bilayer is less relevant to this dimer structure, at least for 
the two phospholipids used in the present example [65]. The study on GpA [90,94] and 
bacteriorhodopsin [76] demonstrated that the folding of individual TMS is comparable 
with the overall conformations of these domains in proteins. 
This experimental approach could be used not only for structural studies, but also for 
studying functional properties of the peptide. The peptides representing TMS of nicotinic 
acetylcholine receptor [95], cystic fibrosis chloride channel [96] and uncoupling proteins 
[97] showed functional properties comparable to the native proteins.  Results of these 
studies indicate that individual TMS can assume membrane-integrated conformations and 
form native-like interactions leading to formation of ion channels [74]. Another study 
demonstrating channel-like conductance of TM peptide was performed by Betz and co-
workers [98]. In glycine receptor (GlyR) channel-like conductance profiles were studied 
for TM helix 2 and 4. The channel- like conductance was demonstrated for TM helix 2, but 
not for TM helix 4. Channel activity of TM helix 2 was corroborated and it was 
furthermore shown that TM helix 1 of GlyR is not conductive [99]. 
The most complex and challenging environment for investigating TM peptides are 
biological membranes. In addition to an asymmetric lipid bilayer matrix, native membranes 
contain many different proteins and glycoproteins which, depending on cellular 
compartment and cell type, can literally outweigh their lipidic components [65]. Among 
other complications, membranes in live cells are exposed to the action of a huge arsenal of 
enzymes and trafficking systems that continuously work to maintain or change membrane 
composition, curvature, fluidity, permeability, and so forth. Several peptic inhibitors of 
membrane protein oligomerization and function were reported, including peptides against 
ErbB2 [100], ErbB1 [101], and Escherichia coli methyl-accepting chemotaxis protein II 
(MCP-II, formerly known as aspartate receptor Tar) [102,103], for more details see review 
[65]. Nevertheless, to our knowledge, there has been no functional study applying the TMS 
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experimental approach to a secondary active transporter. However, ion channels and 
secondary active transporters may not be structurally so different [104,105]. It has been 
recently shown, that ClC-ec1 (prokaryotic homolog of ClC chloride channels) functions as 
an exchange pump [106]. Moreover, some unusual transport properties of Nramp proteins 
described previously can be interpreted in terms of channel-like mechanism [107]. 
1.4.2 TMS of eukaryotic homolog from the Nramp family 
So far, TMS3, TMS4 and TMS6 of eukaryotic DMT1 (Nramp2) [81,82,108,109] and 
of eukaryotic Nramp1 [83,84,110] have been studied exclusively from the structural point 
of view. It has been shown that TMS4 of Nramp1 is buried more deeply in model lipid 
bilayers than TMS3. The insertion position of TMS4 in the model membrane is affected 
less by pH than the position of TMS3 [110]. These experiments have also demonstrated 
the importance of Asp
192
 located in TMS4 of Nramp2 for manganese binding [83]. 
Mutation at this position in Nramp2 (D192A) was previously shown in in vivo experiments 
to attenuate the uptake of cobalt and iron in cells [111]. For TMS6 of eukaryotic DMT1 it 
was shown that, the His
267
 locates near the central part of the extended segment of 
the peptide, while the His
272
 is involved in the α-helical folding. The mutation of H267A 
leads to disappearance of the flexibility in the central portion of the peptide by 
the formation of more helical folding. In the contrary, the mutation H272A results in an 
unfolding of the N-terminal helix while keeping the helical structure of the C-terminal part. 
No obvious difference in the structure is observed for each of the three peptides at different 
pH values. The specific “α-helix-extended segment-α-helix” structure of TMS6 may have 
an important implication for the binding of the transporter to H
+
 and metal ions and 
the conformation change arising from the mutations of two highly conserved histidines 
may be correlated to the deficiency of the transport activity of DMT1[109]. 
Important transmembrane segments of MntH E. coli used in this study contain several 
conserved amino acid residues. It has been suggested that the most important residues for 
the transport function of protein are located within TMS1, TMS3 and TMS6 (helical wheel 
projections of TMSs are shown in Fig. 1.5) [60,63,112]. Altogether, MntH is composed 
from eleven transmembrane segments. The N–terminus of the protein is located 
in cytoplasm and its C–terminus is exposed to the periplasmic side of the membrane 
as confirmed for MntH of E. coli [62,113]. 
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Figure 1.5 Theoretical projection of helical wheels of TMS1, TMS3 and TMS6 (projection created on 
http://rzlab.ucr.edu/scripts/wheel/wheel.cgi) 
The first functionally important transmembrane segment is TMS1. This segment 
contains two important and specific conserved residues Asp
34
 and Asn
37
, which are 
necessary for binding and transport of H
+
 and Me
2+
. The TMS1 Asp residue is part of 
a conserved DPGN motif that has been subjected to mutagenesis in studies using MntH or 
Nramp2 homologs showing loss of Me
2+
 uptake caused by Gly exchange [112,114]. 
The carboxyl end of Nramp2 TMS1 and adjacent extra loop were implicated in Me
2+
 
binding and coupling of Me
2+
 uptake to the proton-motive force [114]. 
TMS3 is the most hydrophobic segment. There is one positively charged residue 
located in the adjacent cytoplasmic loop (Arg
91
). More interesting are three negatively 
charged residues (Glu
102
, Asp
109
 and Glu
112
). All three residues play important roles in 
the manganese transport. Mutation of these residues caused from decrease of transport to 
total loss of function (E102D) [112]. 
Haeming and Brooker (2004) proposed in their study a hypothetical model of 
the metal binding site within MntH, based on the results of radioactive Mn
2+
 uptake into 
bacteria (Fig. 1.6). In this model, four residues, Asp
34
, Asn
37
, Asp
109
, and Glu
112
, form 
a site for the binding of Mn
2+
. Pro
35
, Gly
36
, and Gly
115
 may cause distortions in the helical 
periodicity of TMS1 and TMS3 that helps to form this binding pocket [112]. Even though 
this model seems to be preliminary, interaction of TMS1 and TMS3 was investigated in 
this study. 
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Figure 1.6 Hypothetical model for the binding of Mn2+ to MntH. In this model, four residues, Asp34, 
Asn
37
, Asp
109
, and Glu
112
, form a site for the binding of Mn
2+
. Pro
35
, Gly
36
, and Gly
115
 (not shown in 
the figure) may cause distortions in the helical periodicity of TMS1 and TMS3 that help to form this binding 
pocket. [112] 
The sixth transmembrane segment of both eukaryotic and bacterial Nramps is one 
of functionally important segments in these proteins. It has been hypothetesized, that 
TMS6 is essential in metal dependent proton transport in Nramps. There are several reports 
demonstrating the effect of the mutations of conserved histidine pair located at this TMS 
[111,115]. The conserved histidine residue His
211
 (in MntH from E. coli) is functionally 
important in bacterial MntH [60,63] and homologous H
267
 in eukaryotic Nramp2 [111]. 
According to the previous studies H211A preserved bacterial sensitivity to all the metals 
that were tested [63]. E. coli MntH transport properties were thus better preserved in 
the H211A mutant than in the H211Y mutant. The relatively well-preserved activity of 
E. coli MntH H211A thus suggests that the H211Y substitution impaired MntH transport 
due to the different acid-base properties of His and Tyr residues [63]. 
Modeling of Nramp homologs on the LeuT/SLC6 structure suggests that in 
the structure of full-length protein TMS1 and TMS6 could form a pair of discontinuous 
helices, each composed of an extended peptide chain interconnecting two shorter α–helices 
[60]. The model suggests an internal symmetry including two domains, made of TMS1-
TMS5 and TMS6-TMS10, similarly folded but in inverted orientation with respect to 
the membrane, with discontinuous helices TMS6 and TMS1 located near the central cavity 
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of the protein [60]. Similar pairs of discontinuous helices constitute a characteristic feature 
in structures of five cation transporters [116]. 
The main objective of this study was to study the three interesting transmembrane 
segments of E. coli MntH and their possible interactions. It was investigated to what extent 
their function reflects the original function of the full-length protein. The secondary 
structure of these three synthetic peptides corresponding to the TMS1, TMS3 and TMS6 of 
E. coli MntH was studied in different environments. Structural studies of individual 
segments and two single-point mutation of TMS6 (H211A and H211R) were performed to 
observe their interaction with lipid membranes and their channel-forming properties in 
the presence and absence of metal ions. In addition, for the possible interaction between 
the segments themselves studies of two mixtures of TMS 1+3 and TMS 1+6 were 
performed. 
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2. Materials and Methods 
2.1 Materials 
All the peptides used in this study were synthesized by Vidia Inc. (Jesenice u Prahy, 
Czech Republic). 
TMS1 peptide (H–K16MRLALMGPAFIAAIGYIDPGNFATNIQ43–NH2) corresponds to 
residues 16–43 of E. coli MntH transporter (UniProtKB/Swiss-Prot database - acc. no. 
P0A769). Peptide mass (2991.58) checked by mass spectroscopy (2992.5 for [M+1]
+
) and 
the purity assessed by HPLC to be 91.9 %. 
TMS3 peptide (H- P90RPVVWFYWVQAEIIAMATDLAEFIGA116–NH2) corresponds to 
residues 90–116 of E. coli MntH transporter (UniProtKB/Swiss-Prot database - acc. no. 
P0A769). Peptide mass (3093.7) checked by mass spectroscopy (3093.5 for [M+1]
+
) and 
the purity assessed by HPLC to be 97.2 %. The peptide was practically insoluble in buffer 
and stock solutions were prepared in 2,2,2-trifluorethanol (TFE). 
TMS6 peptide (H–T193SEAVFLAAGVLGATIMPHVIYLHSSLTQ221–NH2) corresponds 
to residues 193–221 of E. coli MntH transporter (UniProtKB/Swiss-Prot database - acc. no. 
P0A769). Peptide mass (3026.6) was checked by mass spectroscopy (1513.8 for [M+2]
2+
, 
1010 for [M+3]
3+
 and 757.2 for [M+4]
4+
) and the purity assessed by HPLC to be 95.2%. 
TMS6-OH peptide (H–TSEAVFLAAGVLGATIMPHVIYLHSSLTQ–OH) with a free C-
terminus was also present in this study. Peptide mass (3025.6) was checked by mass 
spectroscopy (1514.1 for [M+2]
2+
 and 1010.2 for [M+3]
3+
) and the purity assessed by 
HPLC to be 94.2%. 
H211A mutation (H–TSEAVFLAAGVLGATIMPAVIYLHSSLTQ–NH2), its peptide 
mass (2958.59) was checked by mass spectroscopy (1480.8 for [M+2]
2+
; 987.4 for [M+3]
3+
 
and 740.8 for [M+4]
4+
) and the purity assessed by HPLC to be 93.2%.  
H211R mutation (H–TSEAVFLAAGVLGATIMPRVIYLHSSLTQ–NH2), its peptide 
mass (3043.65) was checked by mass spectroscopy (1523.2 for [M+2]
2+
; 1015.7 for 
[M+3]
3+
 and 762 for [M+4]
4+
) and the purity assessed by HPLC to be 96.3%. 
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Lipids including the E. coli polar extract (67 % phosphatidylethanolamine, 23.2 % 
phosphatidylglycerol, 9.8 % cardiolipin), 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphocholine (POPC), 1-palmitoyl-2-oleoyl-phosphatidylethanolamine (POPE), 1-
palmitoyl-2-oleoyl-3-phosphatidylglycerol (POPG), 1,2-diphytanoyl-sn-glycero-3-
phosphocholine (DPhPC) and 1,2-diphytanoyl-sn-glycero-3-[phospho-rac-(1-glycerol)] 
(DPhPG) were obtained from Avanti Polar Lipids, Inc. and stored as chloroform solutions 
at -30˚C. All other chemicals were of high-purity reagent grade and used as received. 
2.2 Methods 
2.2.1 Single-Channel Measurements 
The patch clamp technique was first used to resolve currents through single 
acetylcholine-activated channels in cell-attached patches of membrane of frog skeletal 
muscle [117]. The method they used (described by [118]) and subsequent refinements 
[119] have led to techniques for high resolution recording of current in excised membrane 
patches in addition to those that remain cell-attached. Single channel recording gives 
information about unitary conductance and kinetic behaviour of ionic channels already 
partly investigated by classical voltage clamping and by noise analysis; it is also leading to 
the discovery of new classes of ion channel [120]. The single channel recording technique 
could be used to record channels in living organism, excised tissues, artificially grown 
tissues and synthetic lipids. 
In our study, a stable lipid bilayer is formed on the tip of a glass micropipette. This is 
achieved by upward and downward movement of the patch pipette (double–dip method, 
Fig. 2.1) [121]. The conductance is observed after applying voltage to the measuring 
pipette. The pattern of successive conductance levels within a single burst of multi-level 
openings of TMS channel provides a possible evidence for the helix bundle (or barrel-
stave; [122]) model of channel formation. A progression of conductance levels may be 
calculated using a simple cylinder-equivalent model for channel formation by helix 
bundles [123-125]. The conductance of the pore [126] is calculated using these equations: 
   (2) 
   (3) 
29 
 
Where G is the observed conductance [S], r is the radius of the pore [nm], and N is 
the number of aggregated helices. The radius of helix (R) is estimated as 0.5 nm; the helix 
length (l) for 1 residue in peptide is 0.15 nm; and the resistivity of 500 mM KCl solution 
calculated from limiting ionic conductance at 25 °C is 0.13 Ω m [127]. 
 
Figure 2.1 Double–dip method of forming a bilayer on the tip of micropipette 
Patch–clamp experiments in this study were conducted utilizing the pipette–dipping 
technique as described earlier [121]. Experiments were performed using Axopatch 200B 
amplifier and Digidata 1322A acquisition system (Axon Instruments, USA), and the data 
were collected utilizing low-pass filter (1 kHz) during recording. Experiments were 
monitored and the data were analyzed with the pClamp 9.2 software (Axon Instruments). 
Patch pipettes were made of premium custom patch glass (Warner Instruments, USA), and 
pulled through a two-pull method by a pipette-puller (Narishige PP-830, Japan) to give 
approximate tip diameters of 1 μm. The pipettes were then filled with electrolyte and used 
immediately. 
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Patch clamp measurements were performed in 5 mM HEPES-citrate, 500 mM KCl, pH 
5.0. Manganese (1 mM MnCl2) or magnesium (1 mM MgCl2) was present on both cis- and 
trans-sides when indicated. The peptide was initially dipped into the pipette-filling 
electrolyte solution (cis–side) at 1 μM final concentration.  In order to create lipid 
monolayer, appropriate amount of lipid mixture was evaporated with a mild flow of 
nitrogen and re-dissolved in pentane (10 mg/ml). About 1-2 μl of the lipid solution in 
pentane was then carefully spread on the surface of polystyrene Petri dishes (3.5 cm and 
4 cm diameter) and left to evaporate. The formation of bilayer seal was monitored as 
a change in resistance from ~20 MΩ when the electrode tip was placed under the lipid 
surface, to ~ 1-10 GΩ after formation of the bilayer seal on the tip of the micropipette. 
Typically at resistances higher than 10 GΩ, lipid multilayer could be stacked at the tip of 
the pipette and stable seals (composed of bilayer) could not be formed.  Blank solutions in 
the absence of peptide were used for control experiments. Ion channel-like conductance 
was not observed in these controls. All measurements were done at room temperature 
(20ºC). 
2.2.2 Preparation of Liposomes (SUVs) 
Small unilamellar vesicles are single-walled vesicles of uniform diameter. SUVs were 
prepared from E. coli polar lipid extract or mixture of lipids, DPhPC/DPhPG (3:1, w/w), 
POPC/POPG (3:1, w/w) and POPE/POPG (3:1, w/w) respectively. The appropriate amount 
of lipids in chloroform solution was evaporated under a stream of nitrogen in a round-
bottomed flask. The lipids were further dehydrated under vacuum overnight, and then re-
hydrated with 10 mM Tris and 100 mM NaF buffer, pH 7.4, where multilamellar vesicles 
were formed. The mixture was sonicated with probe tip sonicator until a clear homogenous 
dispersion was obtained. The diameter of liposomes after sonication was estimated to be 
~ 20-50 nm. The liposome dispertion was then centrifuged for 15 minutes at 14,000 rpm 
at 16°C temperature to remove titanium particles and other impurities. The lipid dispersion 
used for spectroscopic measurements was homogeneous and did not show significant light 
scattering in the 200-600 nm UV/visible range. The prepared SUV dispersion was stable 
and stored in dark at 4°C. 
2.2.3 Circular Dichroism 
Circular dichroism (CD) spectroscopy is a useful technique for the analysis of 
secondary structure of proteins and peptides in various environments. CD refers to 
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the differential absorption of two circularly polarized components of equal magnitude. 
When the light passed through an optically active sample, the left and right components are 
absorbed to different degrees, and so the resulting radiation would possess elliptical 
polarization. A CD signal will be observed when a chromophore is chiral (optically active) 
[128]. The CD spectrum of a protein can be divided into two main regions: the far-UV 
region (260-180 nm) measuring transitions involved with the amide peptide backbone and 
revealing important characteristics of the secondary structure of peptide, and the near-UV 
region (320-260 nm), which providing information about tertiary structure. Not only 
the microenvironment of aromatic amino acids and disulfide bonds, but the absorption and 
dipole orientation influences on the signal obtained in near UV [129,130]. Absorption due 
to the peptide bond yields two main transition peaks: a weak but broad n → π* transition at 
around 220 nm and a more intense π → π* transition at 190 nm [128]. Typical 
conformations of peptide obtained by far-UV spectroscopy are shown in Fig. 2.2. Each of 
these conformations gives rise to characteristic shape and magnitude of CD spectrum. 
A typical α-helix has a positive maximum at 192 nm ( → * transition) with a molar 
elipticity (ME) magnitude of 60,000-80,000 deg cm
2
 dmol
-1
 and two negative maxima at 
222 nm (n → * transition) and 208 nm (→ * transition) with a magnitude of about -
36 000 deg cm
2
 dmol
-1
 [131]. The CD spectrum of a β sheet has the  → * transition 
around 195-200 nm, has a magnitude of 30,000-50,000 deg cm
2
 dmol
-1
, and has the n → 
* transition at about 215-220 nm, with a magnitude of -10,000 to -20,000 deg cm2 dmol-1. 
The spectrum generally correlated with the random conformation has a large negative 
maximum band around 200 nm, with the magnitude of -20,000 deg cm
2
 dmol
-1
, and a small 
positive peak or a shoulder with a small negative value at 220 nm [131]. 
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Figure 2.2 Far-UV CD spectra of typical conformations. The spectra are denoted by: (―) α-helix,(– – –) 
β-sheet, (••••) type I β-turn, (-׀-׀-) poly (Pro) II helix, (----) irregular structure [128]. 
The experimentally obtained spectra are converted from elipticity (θ) in 
millidegrees to molar elipticity ([θ]) according to this equation (4): 
  (4) [129]  
After this conversion, the secondary structure of the protein is estimated, using 
deconvolution methods with a specific protein database. These methods compare the CD 
spectrum with CD spectra of known proteins from the different database. There are a few 
suitable programs for this analysis: BELOK (two-step ridge regression), BPNN 
(backpropagation neural network), CCA (convex constraint analysis), CONTIN-LL (ridge 
regression), K2D (learning neural network), SELCON3 (Self-Consistent Method), SSE 
(secondary structure estimation) and VARSLC and CDSSTR (variable selection) 
[132,133]. 
In our study, CD spectra were recorded on an AVIV 215 spectropolarimeter (Aviv 
Biomedical, USA). For all far-UV measurements a rectangular quartz cuvette of 1 mm 
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pathlength was used. Spectra were collected from 260 to 190 nm at 0.5 nm intervals with 
a 0.5 nm/s scanning speed at 25°C temperature.  For each sample four scans were averaged 
and blank spectra obtained under identical conditions were subtracted. Samples were 
equilibrated at room temperature for ~15 min prior to measurement. All measurements 
were carried out in 10 mM Tris, 100 mM NaF (pH 7.4). Trifluoroethanol (TFE - 25% or 
50% v/v), 1 mM SUVs or SDS were present, when indicated. The final concentration of 
peptide in the sample in all measurements was 20 μM. 
The results are expressed as the mean residue ellipticity. The contents of secondary 
structures were calculated according to the Sreerama–Woody method on 
the DICHROWEB website (http://www.cryst.bbk.ac.uk/cdweb/html/home.html) using 
CONTIN–LL algorithm (with a 42–reference set) [134]. It is important to note that 
the deconvolution analysis method used is a rough estimate of structural composition, since 
the reference data set used for calculating secondary structure content is primarily based on 
known structures of soluble globular proteins and not membrane proteins. It has been 
shown that reference databases derived from soluble proteins do not always produce 
accurate results when applied to membrane protein CD analysis [135]. 
2.2.4 Reverse-phase High performance liquid chromatography (RP-
HPLC) 
High performance liquid chromatography is a technique that has arisen from 
the application of theories and instrumentation originally developed for gas 
chromatography to liquid chromatography [136]. HPLC is frequently used to separate, 
identify, and/or quantify virtually any sample based on their idiosyncratic polarities and 
interactions with the column's stationary phase. HPLC utilizes different types of stationary 
phase (typically, hydrophobic saturated carbon chains), a pump that moves the mobile 
phase(s) and analyte through the column, and a detector that provides a characteristic 
retention time for the analyte (Fig. 2.3). Analyte retention time is dependent on the strength 
of its interactions with the stationary phase, the ratio/composition of used solvents, and 
the flow rate of the mobile phase [137]. 
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Figure 2.3 Reversed-Phase HPLC column (www.waters.com) 
RP-HPLC is a system where the column stationary phase matrix is non-polar and 
the mobile phase is a polar mixture of water plus polar organic solvents such as methanol 
and acetonitrile. RP-HPLC has both analytical and preparative applications in the area of 
biochemical separation and purification. RP-HPLC separates molecules on the basis of 
differences in their hydrophobicity and amphiphilicity. The components of the analyte 
mixture pass over stationary-phase particles bearing pores large enough for them to enter, 
where interactions with the hydrophobic surface removes them from the flowing mobile-
phase stream. The strength and nature of the interaction between the sample particles and 
the stationary phase depends on both hydrophobic interactions and polar interactions. As 
the concentration of organic solvent in the eluent increases, it reaches a critical value for 
each analyte which desorbs it from the hydrophobic stationary-phase surface and allows it 
to elute from the column in the flowing mobile phase. Since this elution depends on 
the precise distribution of hydrophobic residues in each species, each analyte elutes from 
the column at a characteristic time, and the resulting peak can be used to confirm its 
identity and estimate its quantity [137]. 
The HPLC system used in this study was composed of a Waters 2996 photodiode array 
detector with a Waters 600 pump, a Waters 600 controller and a Waters 717plus 
Autosampler. The analytical column used for all experiments was from Phenomenex. 
Samples were degassed in a bath sonicator prior to transfer to the autosampler. Typical 
injection volume was 10-15 μl. RP-HPLC analyses were performed on an analytical Luna 
C5 column (250×4.6 mm inner diameter, 5 μm particle size, 100 Å pore size). The initial 
solvent composition was 75% A and 25% B (solvent A: 0.05% TFA in H2O, solvent B: 
0.05% TFA in acetonitrile). The final solvent composition was 0% A and 100% B. 
The runtime was 40 minutes at a flow rate of 0.5 ml/min. Equilibration time between two 
runs, where initial conditions of solvents were restored was 12 min. Retention times were 
recorded at room temperature. 
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3. Results 
3.1 TMS1 
The first and probably the most interesting transmembrane segment, TMS1, 
corresponds to residues 16–43 of E. coli MntH transporter. This segment contains 
the "Nramp signature", a highly specific and conserved sequence motif DPGN at its C-
terminus. Within this segment, there is a negative charge (Asp
33
) near the C-terminus and 3 
positively charged amino acids are located near the N-terminus adjacent to the cytoplasmic 
loop (Arg
15
, Lys
16
, Arg
18
). To explore the secondary structure of this TM domain, its CD 
spectra are measured as a single peptide and in mixture with other TM segments, TMS3 
and TMS6 in various environments, such as aqueous solutions, the membrane mimetic 
solvent TFE and the detergent SDS, as well as small unilamellar phospholipid vesicles. 
3.1.1 CD analysis 
The CD spectra of TMS1 in buffer showed dominantly unordered structures. 
The spectra of mixtures of peptide segments in aqueous solution were comparable to that 
of TMS1 (Fig. 3.1). The overall shapes of the spectra with two negative maxima at 
~ 220 nm and ~ 198 nm imply a dominantly random coil conformation with some ordered 
structures.  As exhibited in the CD spectra, no significant conformational change was 
observed in the presence of manganese ions, the substrate of the full-length MntH protein 
(Fig. 3.1). 
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Figure 3.1 CD spectra of TMS1 and mixtures TMS 1+3 and TMS 1+6 in buffer in the presence and 
absence of manganese ions. 
In contrast to the spectra in buffer, CD spectra in SDS micelles were significantly 
changed. As seen in Fig. 3.2A TMS1 and peptide mixtures became dominantly helical in 
SDS micelles, known to induce and stabilize secondary structures. According to Zhong & 
Johnson, -helical structure is more likely to be induced at or above critical micellar 
concentration of SDS [138]. The CD spectra of TMS1 in SDS were concentration 
dependent with the 222/208 ratio changing from 2 (below CMC) to 1.5 (above CMC). 
These results could imply self-association of the peptide as was shown in coiled-coils. 
Coiled coils are common structural motifs, consisting of two to five amphipatic -helices 
wrapped around each other to form supercoils [139]. The spectrum of TMS1 in SDS 
micelles had the characteristics of an –helical conformation with two negative maxima at 
222 and 208 nm and a positive maximum at 193 nm (Fig. 3.2A). The CD spectra of TMS1 
in aqueous solutions of TFE (from 25% to 50%) also depicted α-helical conformations 
with 222/208 ratio of ~ 0.9 (Fig 3.2B). The observed –helical content of TMS1 in SDS 
(above CMC) was comparable to that of TMS1 in TFE/water environment (Table 1 in 
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Appendix1). The effect of manganese metal ions on TMS1 conformation in SDS was 
insignificant, however in TFE this effect was more conspicuous (2.8% vs. 12% increase of 
helicity).  
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Figure 3.2 CD spectra of TMS1 in different concentration of (A) SDS and (B) TFE 
The conformation of TMS1 was further explored in different lipid vesicles. CD spectra 
of TMS1 in SUV of following lipid compositions: POPC/POPG, DPhPC/DPhPG, 
POPE/POPG (all in molar ratio 3:1) and E. coli polar lipid extract (67% PE, 23.2% PG and 
9.8 % CL) are shown in Fig. 3.3. These lipid membranes represent both liquid and gel 
phases of bilayers. Under our experimental conditions DPhPC/DPhPG was in the gel 
phase, the same lipid system was also used in the single-channel measurements.  
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Figure 3.3 CD spectra of TMS1 in lipid vesicles of different lipid composition. Spectra are normalized at 
220 nm. 
TMS1 in DPhPC/DPhPG showed the most -helical and ordered structure. 
The character of the spectra was different for other lipid environments. There were two 
negative maximum bands one at 222 nm and the second weaker shoulder-like one at 
208 nm, as well as one positive maximum band at 193 nm. The spectra implied 
the association of helices and possible penetration of TMS1 into the DPhPC/DPhPG 
bilayer. However, for other three lipid systems the -helical content was less than 15%. 
The difference in secondary structure may be due to the different physical properties of 
the lipid vesicles under our experimental conditions. As previously mentioned, 
DPhPC/DPhPG was in gel phase and all the other lipid systems were in liquid phase. 
Based on the CD spectra shown in Fig. 3.3 the conformation in POPC/POPG and E. coli 
polar lipid extract vesicles is comparable. Even though POPE/POPG vesicles are closer in 
composition to the E. coli polar lipid extract, the normalized mean residue elipticity at 
220 nm of the peptide in POPE/POPG is almost three times higher than in POPC/POPG 
and E. coli polar lipid extract. Possibly the secondary structure of TMS1 is more dependent 
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on the physical characteristics (phase) of the lipid vesicle, rather than the composition of 
lipid vesicles. 
3.1.1.1 Effect of metal ions on TMS1 conformation 
The secondary structure of TMS1 was also studied in the presence of divalent metal 
ions as possible substrates. The effect of manganese as the physiological substrate for 
MntH protein was studied under the previously stated experimental conditions. It was 
shown that manganese ions had no significant effect on the conformation of TMS1 in 
aqueous solutions (Table 1 in Appendix 1). According to the deconvolution analysis, in 
25% TFE -helicity in the presence of manganese ions was slightly increased. The same 
effect was observed in 50% TFE. 
In different concentrations of SDS the effect of manganese ions is similar. It increased 
the -helical content on average by 2.5%, whereas the -strand content was decreased. 
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Figure 3.4 CD spectra of TMS1 in DPhPC/DPhPG vesicles in the presence of manganese and cadmium 
ions 
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The influence of cadmium on the secondary structure was also monitored in SUVs. 
Both metal ions should reduce the negative charge on the membrane surface. The effect of 
metal ions was different in each lipid vesicles (Table 3.1). The increase of -helical 
content was observed in DPhPC/DPhPG vesicles only (Fig. 3.4). Both metal ions increased 
the -helix content by ~ 2%. On the other hand, -strand content significantly decreased 
by ~ 5% in the presence manganese ions and ~ 6% percent in the presence of cadmium 
ions. A very different effect on the structure was observed in POPC/POPG vesicles. 
The spectra showed less ordered structures in the presence of both metal ions. 
The percentage of turns in this environment slightly increased (Fig. 1 in Appendix 1). In 
the presence of manganese ions the - helical content slightly decreased. However, for 
cadmium ions there was no change in the -helical content. A similar situation was 
observed in the E. coli polar lipid extract vesicles. The -helix content was decreased in 
the presence of manganese ions (~ 2%) and was not changed in the presence of cadmium 
ions. The structure of TMS1 became slightly more unordered in the presence of these ions 
(Fig. 2 in Appendix 1). In contrast, different effect of metal ions was detected in 
the POPE/POPG vesicles. The secondary structure became more unordered for both metal 
ions (5–7 %). Overall, the ellipticity of the segment was weak (Fig. 3 in Appendix 1). 
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Table 3.1 Deconvolution analysis of TMS1 spectra in lipid vesicles 
  Secondary structure [%]  
  −helix β−strand Turns Unordered 
DPhPC/DPhPG 18.7 36.8 16.7 27.8 
+ 2 mM MnCl2 20.7 32.2 18.3 28.7 
+ 2 mM CdCl2 20.7 31.3 19.9 28.1 
POPC/POPG 13.5 33.4 22.9 30.3 
+ 2 mM MnCl2 12.8 32.0 23.6 31.7 
+ 2 mM CdCl2 13.7 29.7 23.6 33.0 
E. coli polar lipid extract 12.7 33.1 22.4 31.7 
+ 2 mM MnCl2 10.6 32.5 23.3 33.7 
+ 2 mM CdCl2 12.3 33.7 22.0 33.0 
POPE/POPG 10.4 37.9 22.7 29.0 
+ 2 mM MnCl2 9.0 31.6 22.9 36.5 
+ 2 mM CdCl2 6.2 39.1 21.1 33.5 
3.1.2 Electrophysiological studies using patch clamp 
The channel–forming properties of peptides were studied in phospholipid bilayers 
(DPhPC/DPhPG 3:1 molar ratio) formed at the tip of micropipettes at 20 °C (room 
temperature). Electrophysiological studies were performed on a lipid system with sufficient 
mechanical strength. Blank solutions were prepared as negative controls to eliminate 
the possibility of leakage artifacts. No ion channel-like conductance was observed in these 
controls. Ion channel activity of alamethicin and gramicidin was also monitored in this 
lipid bilayer system as positive control. Both of these well-known ion channel peptides 
showed the expected conductance values comparable to the previously published results 
[121]. 
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Figure 3.5 Representative current patterns of TMS1 (in 5 mM HEPES pH 5.0, 500 mM KCl, on both 
sides of the micropipette) (A) in the absence of 1 mM MnCl2 (+50 mV) (B) in the presence of 1 mM MnCl2 
(+55 mV) 
In HEPES-citrate buffer at pH 5.0, the presence of manganese had no significant 
impact on the probability of occurrence of channels formed by TMS1 (36% in the presence 
of manganese, 38% in the absence) (Fig. 3.5). In both cases single-channels were observed, 
with conductance values of 23.1 ± 10.7 pS and 25.4 ± 7.9 pS, respectively. Comparing 
these conductance values to the other transmembrane segments (TMS3, TMS6 see sections 
3.2.2 and 3.3.2), TMS1 showed the lowest conductance. The ion conducting unit of TMS1 
ion channel could be modeled by a helical bundle composed of several peptide molecules. 
The measured conductance values and their comparison with the calculated values derived 
from the cylindrical-bundle pore model [126] imply the formation of oligomeric helical 
bundle conducting unit composed of three helices. Possible association of the TMS1 
helices is also supported by the CD spectra of this peptide in DPhPC/DPhPG lipid vesicles 
exhibited in Fig. 3.4. 
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3.2 TMS3 
TMS3 is the most hydrophobic segment among all studied segments in this study. This 
segment contains three negatively charged residues (Glu
102
, Asp
109
 and Glu
112
) in 
the transmembrane part, close to periplasm and one positively charged arginine (Arg
91
) in 
the adjacent cytoplasmic loop. It also contains two tryptophan residues inside 
the transmembrane part closer to cytoplasm. The presence of Trp residues is important for 
fluorescence experiments. These residues could have some functional or structure 
stabilizing roles in the whole protein. The TMS3 sample contained ~ 3.5% TFE, due to 
the insolubility of the segment. This concentration of TFE does not interfere with our 
spectroscopic or electrophysiological measurements. 
3.2.1 CD analysis 
To observe the secondary structure of TMS3, CD analysis was performed in different 
environments. The CD spectra of TMS3 measured in TFE from 3.5% to 50% are shown in 
Fig. 3.6. TMS3 in 3.5% TFE showed mostly -strand structure, with a positive maximum 
~ 200 nm and a negative maximum at 230 nm. With increasing percentage of TFE the -
helical content was increased. In 25% TFE the first negative maximum was at 221 nm, 
the second negative maximum was observed at 210 nm. Moreover, in 50% TFE TMS3 
showed a representative –helical structure with two negative maxima (222 nm and 
208 nm) and one positive maximum around 193 nm (Fig. 3.9). 
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Figure 3.6 CD spectra of TMS3 at different concentrations of TFE 
CD spectra of TMS3 at different concentrations of SDS had an α-helical characteristic 
with two negative maxima at 222nm and 208 nm and one positive maximum ~193 nm 
(Fig. 3.7). Surprisingly, according to the deconvolution analysis, the spectra measured in 
SDS below CMC were more helical compared to those above CMC (by almost 10%). 
However, the –helical content below and at CMC was comparable (51.5% and 52% 
respectively). The spectrum above critical micellar concentration had 41.1% –helical 
content (Table 3 in Appendix 2). 
Similar to TMS1 in the previous section, the ability of TMS3 to penetrate in the lipid 
vesicle and the secondary structure in different SUVs were studied. TMS3 was mixed 
directly with lipid vesicles. 
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Figure 3.7 CD spectra of TMS3 at different concentrations of SDS in the absence (solid lines) and 
presence of manganese ions (dashed lines) 
CD spectra of TMS3 in lipid vesicles of different lipid compositions are shown in 
Fig. 3.8. In two lipid systems (DPhPC/DPhPG and POPC/POPG) the segment was mostly 
β-sheet (39% for DPhPC/DPhPG and 37% for POPC/POPG, Table 3.2) and unordered 
structure with very low elipticity. In comparison to other studied segments, TMS3 was 
the least α-helical structure in DPhPC/DPhPG. Whereas the secondary structure of 
TMS1seemed to be more dependent on the physical characteristics (phase) of the lipid 
system, TMS3 was influenced more by the composition of lipid vesicles. 
Phosphatidylcholine (PC) based lipid systems do not induce an -helical structure in 
TMS3. PC is a zwitterionic lipid and PG has a negative charge. On the other hand PE lipids 
are also uncharged. The overall charge of lipids plays an important role in the secondary 
structure of the segment in different lipid systems. But the different properties of these 
lipid systems are the reason why the secondary structure of mostly negatively charged 
TMS3 showed more -helical structure in PE based lipid systems. 
Phosphatidylethanoamine in comparison to phasphatidylcholine has two double bonds, 
which makes PE more rigid than PC. 
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In E. coli polar lipid extract vesicles the -helicity of TMS3 increased in comparison to 
phosphatidylcholine lipids by more than 10% to ~ 20%. The -strand conformation is still 
significantly higher than -helix in this lipid environment. 
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Figure 3.8 CD spectra of TMS3 in various lipid vesicles 
A spontaneous insertion of TMS3 into lipid bilayer surface was detected in E. coli 
SUVs [140]. The CD spectrum of TMS3 was a combination of -sheet and -helix, with 
a negative maximum at 228 nm and a positive maximum at 196 nm (Fig 3.8). TMS3 is 
believed to partially penetrate into the E. coli polar lipid extract vesicles. Heating of 
the sample to 40°C neither induced helicity nor promoted the penetration (Fig. 11 in 
Appendix 2). The peptide in the second lipid system composed of POPE/POPG showed 
a higher -helical content, than the PC environment. The spectrum is different from E. coli 
polar lipid extract, with a negative maximum at 220 nm and a positive maximum at 
194 nm. Comparing to E. coli polar lipid extract vesicles (containing PE, PG and 
cardiolipin) the spectrum of the peptide is more unordered (Fig 3.8, Table 3.2). Cardiolipin 
could have a role in inducing the secondary structure in this system. 
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3.2.1.1 Effect of metal ions on TMS3 conformation 
Similar to TMS1, the secondary structure of TMS3 was also studied in the presence of 
divalent metal ions. It was shown that manganese ions had no significant effect on 
the conformation of TMS3 in TFE. In 3.5% and 50% TFE manganese slightly induced 
helicity (Table 3 in Appendix 2). According to the deconvolution analysis TMS3 did not 
gain structure in 25% TFE, even tough the shape spectra of TMS3 changed (Fig. 3.6). 
The presence of 2 mM MnCl2 in all SDS measurements results in minor decrease of –
helical content by 2.3 ± 1.4%. In contrast to TMS1, the overall characteristic of the spectra 
in different concentrations of SDS was not changed (Fig 3.7, Table 3 in Appendix 2). 
Table 3.2 Deconvolution analysis of TMS3 spectra in lipid vesicles 
  Secondary structure [%]  
  α−helix −strand Turns Unordered 
DPhPC/DPhPG 5.5 39.4 22.0 32.8 
+ 2 mM MnCl2 13.5 36.8 22.6 32.5 
+ 2 mM CdCl2 10.1 33.3 24.3 32.1 
POPC/POPG 7.3 37.0 22.7 33.0 
+ 2 mM MnCl2 8.6 35.6 23.5 32.4 
+ 2 mM CdCl2 9.7 34.2 24.2 32.0 
E. coli polar lipid extract 19.6 34.9 23.1 22.3 
+ 2 mM MnCl2 15.5 32.6 23.5 28.3 
+ 2 mM CdCl2 18.1 30.9 22.8 28.1 
+ 2 mM CaCl2 10.0 34.6 23.7 31.6 
+ 2 mM MgCl2 17.2 29.4 25.2 28.3 
POPE/POPG 13.5 33.1 22.5 30.8 
+ 2 mM MnCl2 14.0 32.8 22.0 31.0 
+ 2 mM CdCl2 20.3 28.1 22.4 29.2 
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Metal ions have more significant influence on the secondary structure of the TMS3 in 
lipid vesicles. TMS3 in DPhPC/DPhPG vesicles seemed to gain more -helical content (α-
helix increased by 8% in the presence of manganese and by ~5% in the presence of 
cadmium ions). Fig. 9 in Appendix 2 shows that the CD spectra in the presence of metal 
ions are changed. In POPC/POPG vesicles the presence of metal ions increased 
the elipticity of spectra (Fig. 9 in Appendix 2). The maximum of the spectra was not 
clearly detected due to the scattering of the sample below 193 nm. The secondary structure 
became slightly more ordered in the presence of manganese and cadmium ions (Table 3.2). 
Various divalent metal ions (manganese, cadmium, magnesium and calcium) were used 
to investigate the effect of these ions on the secondary structure of TMS3 in E. coli polar 
lipid extract (Table 3.2). In contrast to the effect of the metal ions in all other lipid systems, 
these metal ions did not increase the - helical content of the peptide segment (Fig. 10 in 
Appendix 2). Inversely, some metal ions made the secondary structure of TMS3 more 
unordered. Manganese ions did not significantly influence the structure. A slight increase 
of -sheet structure was observed at the expense of decrease in of –helical content (~ 4%) 
(Table 3.2). Significant difference in the shape of the spectra was observed in the presence 
of cadmium and magnesium ions. In the presence of these two metal ions, the negative 
maximum at 228 nm changed to two negative maxima at 224 nm and 209 nm. 
The maximum slightly red shifted to 195 nm. The most significant distortion of secondary 
structure was observed in the presence of calcium ions (Fig. 10 in Appendix 2). 
In POPE/POPG vesicles the presence of metal ions slightly increased the α-helicity of 
the segment. The CD spectra of TMS3 in the presence of manganese ions had a shoulder at 
210 nm. In the presence of cadmium ions this shoulder shifted to 209 nm. The overall 
elipticity of the spectra was higher (Fig. 12 in Appendix 2). In POPE/POPG, the -helix 
content for TMS3 was 13.5%, and this value increased to ~ 20% in the presence of 
cadmium ions (Table 3.2).  
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3.2.2 Electrophysiological studies using patch clamp 
All the patch clamp measurements were performed under the same conditions as those 
used for TMS1. Channel-like activity was observed for TMS3 only in the presence of 
manganese ions. In the absence of 1 mM MnCl2, on both sides of the pipette, no channel–
like activity was observed. This implicates that for channel activity of TMS3 the presence 
of manganese is essential. It is not clear, whether the effect of manganese ions on TMS3 
channel opening is specific (i.e. Mn
2+
 interacts directly with the peptide) or non-specific. 
The channels were voltage-dependent and showed multiple conductance levels 
(Fig. 3.9). The conductance of ion channels was 30.95 ± 6.8 pS for the first open state, 
48.3 ± 4.6 pS for the second state and 84.7 ± 13.5 pS for the third state. This measured 
conductance values and their comparison with calculated values derived from cylindrical-
bundle pore model [126] imply the formation of conducting units composed by three to 
four helices forming a pore of ~ 0.1 nm diameter.   
-6 -3 0 3
-1000
800000
0 5 10 15 20
-100
90000
 C
o
u
n
t 
(N
)
Amplitude [pA]
C
o
u
n
t 
(N
)
Open 5
Open 4
Open 3
Open 2
Open 3
Open 2
Open 1
Close
2 pA
1 s
Close
Open 1
-40 mVB
5 pA
200 ms
+100 mVA
 
Figure 3.9 Representative current patterns of TMS3 (in 5 mM HEPES pH 5.0, 500 mM KCl, 1 mM 
MnCl2, 1% TFE on both sides of the micropipette) at (A) positive applied voltage (+100 mV) (B) applied 
voltage (-40 mV) 
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Figure 3.10 Current–voltage (I–V) relationships of ion channels formed by the TMS3 
Measurements of reversal potential, in the presence of asymmetric KCl concentrations 
across the bilayer (0.5 M KCl on cis–side, 0.1 M KCl on trans–side), were intended for 
determination of ion selectivity. Reversal potential for TMS3 was -7.8 ± 1.5 mV. 
The permeability ratio from the Goldman–Hodgkin–Katz equation is PCation/PAnion = 1.6 
[126]. This result indicates that TMS3 is a slightly cation selective ion channel. 
The current-voltage relationship is linear, thus the channels formed by TMS3 showed an 
ohmic behaviour. There is no voltage-dependence in the open-closed pattern of 
the individual channels (Fig. 3.10), however the appearance of different conducting states 
was voltage dependent. 
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3.3 TMS6 
The sixth transmembrane segment of both eukaryotic and bacterial Nramps is one of 
functionally most important segments, being involved in the transport and in the coupling 
of both substrates. There have been several reports demonstrating the effect of 
the mutations of conserved histidine pair located at this TMS [111,141]. The conserved 
His
211
 (in MntH from E. coli) is functionally important in both bacterial MntH [60,63] and 
eukaryotic Nramp2 (His
267
 in rat Nramp2) [111].  
The TMS6 segment contains one negatively charged glutamic acid (Glu
195
) at 
the adjacent periplasmic loop. Two histidine residues are located within the transmembrane 
part (His
211
, His
216
). There is one additional histidine residue at the border with cytoplasm, 
which is not part of our synthesized peptide. For this study two versions of TMS6 segment 
were prepared, one with the free C-terminus (TMS6-OH) and second one with amide-
protected C-terminus (TMS6). Also two mutant versions of TMS6, H211R and H211A, 
were synthesized to investigate the influence of H
211
 on the physiochemical properties of 
this peptide. The comparison of secondary structure in aqueous buffer, TFE and the lipid 
systems will be shown in the following section. 
3.3.1 CD analysis 
Circular dichroism of the peptides was studied in the same experimental conditions as 
TMS1 and TMS3. Ellipticities of CD spectra in aqueous buffer were weak (Figure 3.11). 
For TMS6-OH and H211R, these spectra showed dominantly random coil conformations 
with a negative band at 198 nm. The characteristics of CD spectra of H211A and TMS6 
were rather different. The spectrum of H211A had two negative maxima at 222 nm and 
201 nm. TMS6 had one negative maximum at 220 nm and a shoulder at 204 nm. Both 
peptides were without any visible maximum above 190 nm (Fig. 3.11). This 
conformational difference of H211A can be attributed to the higher hydrophobicity of 
the peptide (alanine is more hydrophobic than histidine), which can cause partial 
association of the peptide. The amide-protected terminus of TMS6 could also lead to 
association and stabilization of helices in the buffer (Fig 3.11). TMS6 showed more 
ordered structure in aqueous buffer than TMS6-OH Table 3.3. 
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Table 3.3 Deconvolution analysis of TMS6 peptides spectra in buffer 
  Secondary structure [%] 
  α−helix β−strand Turns Unordered 
TMS6-OH 6.5 37.3 21.8 34.5 
+ 2 mM MnCl2 9.0 33.2 24.0 33.9 
TMS6 6.2 39.6 20.6 33.6 
+ 2 mM MnCl2 9.8 40.6 27.8 21.8 
H211A 6.8 36.6 22.9 33.8 
+ 2 mM MnCl2 4.5 41.3 20.6 33.6 
H211R 7.8 34.1 23.6 34.4 
+ 2 mM MnCl2 6.4 36.7 21.9 35.0 
 
The CD spectra of all the peptides were also measured in the TFE-containing buffer 
(Fig. 13 in Appendix 3). CD spectra of the TMS6-OH and TMS6 in 50% TFE confirmed 
the helix–forming tendency of this peptide domain. Overall, the spectra in these milieus 
exhibited α-helical conformations (Fig. 13 in Appendix 3). Similar results were obtained 
also for both H211A and H211R peptides. These results imply that in the less polar 
hydrophobic environments TMS6 of E. coli MntH has a high potential to form helical 
structures.  
At different concentrations of SDS the secondary structure of each peptide and degree of 
induction of -helix was different. (Fig. 14, Table 4 in Appendix 3). TMS6-OH gained -
helical structure with increasing concentration of SDS (from 18% in 1mM SDS to 31% in 
20 mM SDS). Both mutant peptides showed more helicity than TMS6-OH, with 
the highest -helical content at CMC (54% for H211A, 51% for H211R). Increase in 
the concentration of SDS resulted in the decrease in the helical content of H211A (~10%) 
and a slight decrease in the helical content of H211R (Table 5 in Appendix 3). 
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Figure 3.11 CD spectra of the peptides in aqueous buffer. Solid lines show spectra without manganese 
and dashed lines show spectra in the presence of 2 mM MnCl2. The spectra represent the average of two 
independent experiments. 
The secondary structure of the peptides was also studied in various lipid vesicles. CD 
spectra of all four variation of TMS6 peptide in DPhPC/DPhPG SUVs exhibited 
remarkable changes when compared to those measured in buffer (Fig. 3.12). CD spectra of 
TMS6 peptides in DPhPC/DPhPG vesicles showed two negative maxima at 222 nm and 
210 nm and a positive maximum at 193 nm, implying the formation of a helical 
conformation of the peptide. The helicity of peptides in lipid vesicles increased comparing 
to buffer environment by ~ 10% for TMS6-OH, ~ 15% for H211A, ~ 23% for TMS6 and 
more than 30% for H211R. These significant conformational changes are indicative of 
spontaneous insertion of the peptides into the lipid bilayer. Comparing the free and amide-
protected TMS6 in diphytanoyl vesicles, CD spectra of amide-protected TMS6 showed 
more secondary structure than TMS6-OH. According to the deconvolution analysis -helix 
content of TMS6 was ~ 30% and ~ 16% for TMS6-OH. The amide-protected terminus 
promotes helicity in DPhPC/DPhPG lipid system. The estimated secondary structure 
content is shown in Table 3.4. The order of α-helicity in DPhPC/DPhPG vesicles decreased 
as follows: H211R > TMS6 > H211A > TMS6-OH.  
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Figure 3.12 CD spectra of the peptides in the presence of DPhPC/DPhPG vesicles. Solid lines show 
spectra without manganese and dashed lines show spectra in the presence of 2 mM MnCl2. 
CD spectra of TMS6, TMS6-OH and mutants in POPC/POPG vesicles were 
significantly different from those in diphytanoyl vesicles (Fig.15 in Appendix 3). TMS6 in 
POPC/POPG vesicles had the highest helical content (α-helix ~ 31%) from all studied 
peptides. In contrast, TMS6-OH had the lowest α-helical content – only ~ 8%. Similar to 
previous lipid environment the amide-protected terminus in TMS6 was promoting 
the helicity of the peptide. The spectra of H211A mutant was rather different comparing to 
the others with only one major negative maximum at 222 nm. This mutant had mostly β-
sheet structure (Fig.15 in Appendix 3). 
The last SUVs used to study the secondary structure of peptides were E. coli polar lipid 
extract vesicles. Interestingly, TMS6-OH had comparable -helical content to 
POPC/POPG (~ 8%) in these vesicles. These peptides showed lower helicity in lipid 
vesicles in their liquid phase, and almost double the α-helical content in SUVs in gel phase 
(DPhPC/DPhPG). In E. coli polar lipid extract the highest helicity was observed for mutant 
H211A (~ 24%) (Table 6 in Appendix 3). The CD spectra of TMS6 and H211R were 
comparable. 
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Table 3.4 Deconvolution analysis of TMS6 peptides spectra in DPhPC/DPhPG vesicles 
 Secondary structure [%] 
 -helix -strand Turns Unordered 
TMS6-OH 15.8 38.4 16.6 29.2 
+2 mM MnCl2 19.5 33.0 18.8 28.8 
TMS6 30.4 23.2 19.5 26.9 
+2 mM MnCl2 27.0 25.3 19.5 28.2 
H211A 22.3 34.9 15.7 27.1 
+2 mM MnCl2 31.7 25.9 17.5 25.0 
H211R 42.6 23.1 13.1 21.2 
+2 mM MnCl2 43.8 18.4 15.6 22.3 
 
The secondary structure of TMS6 with amide-protected terminus was more helical than 
TMS6-OH in all lipid environments. The amide-protected terminus seems to promote 
helicity more or less in all studied lipid vesicles. Interestingly the influence of the amide-
protection seems to be more pronounced for PC based lipid vesicles. Whereas the biggest 
increase of α-helical content was observed for POPC/POPG vesicles (by ~ 24%). 
3.3.1.1 Effect of metal ions on conformation of TMS6 peptides 
The presence of manganese divalent ions influenced the secondary structure of 
the peptides in buffer (Fig. 3.11). The most remarkable change was observed for H211A. It 
seems that in the presence of Mn
2+ 
 in aqueous solution the mutant H211A tends to 
associate and form ordered β-structures. 
In both helix-promoting solvents TFE and SDS the α–helical structure of the studied 
peptides became more pronounced in the presence of manganese ions. The only exception 
was TMS6 in 50% TFE; in this case no difference in the spectra was observed (Fig. 13 in 
Appendix 3). 
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Except for TMS6, all peptides studied in SUVs gained helical structure in the presence 
of manganese ions (Fig. 3.12, Table 3.4). The most significant increase of α-helicity in 
the presence of manganese ions was observed for H211A in DPhPC/DPhPG vesicles (by 
~ 9%); it was accompanied by a decrease of β-strand structure.  
The effect of manganese ions and cadmium ions was studied in E. coli polar lipid extract 
vesicles. Similar to the previously mentioned lipid system manganese ions slightly 
increased α-helix content of TMS6-OH, the increase of helicity is more pronounced in 
the presence of cadmium ions. On the other hand, TMS6 and both mutations showed 
decrease in helicity in the presence of both divalent metal ions (Table 6 in Appendix 3). All 
studied peptides became less ordered in the presence of Mn
2+
. 
3.3.2 Electrophysiological studies using patch–clamp 
All the patch clamp measurements were performed under the same experimental 
conditions as those using TMS1 and TMS3. Both TMS6 and TMS6-OH channel–like 
conductance had clear transitions between the open and closed states, when observed under 
acidic pH (pH 5.0 cis- and trans-side) conditions in the presence and absence of manganese 
ions (in 40% of trials with MnCl2 and 56% of trials without MnCl2 for TMS6 and in 42% 
and 35% of trials, respectively for TMS6-OH). The presence of manganese was not 
necessary for ion channel formation but influenced ion channel characteristics. 
The free-terminus TMS6-OH in the absence of manganese showed a multi-state 
channel activity (Fig. 3.13A) with two dominant conductance states. The two open 
conductance states had the conductance values of 273 ± 64 pS and 464 ± 96 pS, 
respectively. The closed state occurred rarely. Values of the first open state were 
comparable to the first open state of the amide-protected TMS6 (Fig. 3.14A). Ion channels 
of TMS6 recorded in the absence of manganese (Fig. 3.14A) showed a multi-state ion-
channel activity, with three dominant conductance values of 293 ± 151 pS, 798 ± 184 pS 
and 1243 ± 378 pS (Fig. 3.14A).  
Both TMS6 peptides showed multi-state channel activity in the presence of 
1 mM MnCl2 at pH 5.0. TMS6-OH showed four clearly defined dominant conductance 
states (Fig. 3.13B). The first conductance state was comparable to those observed without 
manganese ions, 250 ± 20 pS. Similar to TMS6-OH, amide protected TMS6 showed four 
conductance states with one sub-state observed near the first open state. The conductance 
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of the first state in TMS6 was lower compared to TMS6-OH, 81 ± 56 pS. The second state 
in TMS6 had conductance comparable to the first state of TMS6-OH 214 ± 144 pS. 
Analogically to TMS1 and TMS3, the conductance states in the presence of manganese 
were used to estimate the number of helices forming the conducting units using the helical 
bundle model [126]. The conductance values of TMS6-OH imply that the conducting unit 
is formed of four to six helices. Comparably the conducting unit of the amide-protected 
TMS6 segment is formed of five to six helices. 
 
 
 
Figure 3.13 Representative current patterns of TMS6-OH (in 5 mM HEPES pH, 500 mM KCl,) at (A) pH 
5.0 on both sides of the micropipette, (B) pH 5.0 on both sides of the micropipette with 1 mM MnCl2, (C) pH 
5.0 on trans-side and pH 7.4 on cis-side both sides with 1 mM MnCl2 
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TMS6-OH was further studied under asymmetrical conditions (pH 7.4 on the cis-
side and pH 5.0 on the trans-side). This peptide showed multi-state channel activity under 
these experimental conditions (Fig. 3.13C). The reversed case (pH 5.0 cis and pH 7.4 trans) 
did not yield stable membranes and consequently, no channel–like activity was observed. 
In addition, in order to study the effect of other physiologically relevant ions, similar 
experiments with TMS6-OH were also performed for magnesium ions (contrary to Mn
2+
, 
Mg
2+
 is not substrate of full-length MntH protein). In the presence of 1 mM MgCl2 at 
pH 5.0, TMS6-OH did not show any multi-state channel-like activity, but displayed weak 
single-channel activity, however, only rarely (in 18% of the experiments). 
To further characterize the observed ion channels formed by TMS6 and TMS6-
OH, current–voltage relationships were investigated under both symmetrical conditions for 
TMS6 and TMS6-OH and asymmetrical conditions for TMS6-OH (Fig. 3.15). In 
comparison to symmetrical conditions, the average conductance of TMS6-OH ion channels 
were significantly higher (symmetrical: 360 ± 130 pS and asymmetrical: 990 ± 160 pS). 
Interestingly, the reversal potential under asymmetrical conditions was zero (Fig. 3.15D), 
which excluded the possibility that the channels are proton selective. In that case reversal 
potential would be close to the Nerst potential for difference of 2.4 pH units, i.e. -140 mV. 
The presence of manganese ions seemed to have smaller effect on the channel activity than 
the pH conditions. The conductance of the TMS6-OH channel in the presence of Mn
2+
 ions 
under symmetrical pH conditions was higher (360 ± 130 pS) than the conductance in its 
absence (273 ± 64 pS). On the other hand, the first conductance level of TMS6 channel 
was lower in the presence of manganese (81 ± 56 pS), than in its absence (293 ± 151 pS). 
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Figure 3.14: Representative current patterns of TMS6 (in 5 mM HEPES pH 5.0, 500 mM KCl, on both 
sides of the micropipette) (A) in the absence of 1 mM MnCl2 (+30 mV) (B) in the presence of 1 mM MnCl2 
(+70 mV) 
We also examined the channel–forming properties of both TMS6 peptides containing 
the mutation at His
211
. Replacing His
211
 with alanine caused decrease in the channel–like 
activity. In H211A channel–like activity was rarely observed (in 13% of the experiments) 
in the presence of manganese ions. No channel–like activity was observed when His211 
replaced with arginine. 
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Figure 3.15 Current-voltage (I-V) relationship of ion channels formed by TMS6 peptides. Red circles 
represent open state O1 and green circles open state O2. (A) TMS6 pH 5.0 with 1 mM MnCl2 on both sides 
(B) TMS6-OH pH 5.0 on both sides (C) TMS6-OH pH 5.0 with 1 mM MnCl2 on both sides (D) TMS6-OH 
pH 5.0 on cis-side and pH 7.4 on trans-side, both sides with 1 mM MnCl2, dotted lines show linear fit. 
Measurements of reversal potential, at asymmetric KCl concentrations across 
the bilayer (0.5 M KCl on cis-side, 0.1 M KCl on trans-side, pH 5.0 on both sides), were 
performed for determination of ion selectivity of TMS6-OH. It was found that the reversal 
potential in the presence of manganese ions (Vrev= -11.5 ± 1.1 mV) did not differ 
significantly from the value measured in its absence (Vrev= -11.9 ± 3.2 mV). Thus, 
the permeability ratio calculated according to Goldman–Hodgkin–Katz equation [126] is 
almost identical in the presence (PCation/PAnion = 2.02) and absence of manganese 
(PCation/PAnion = 2.06). This finding denotes that the ion channels formed by TMS6-OH are 
weakly cation selective and may have comparable average diameters in the absence and 
presence of Mn
2+
 ions. 
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3.4 Peptide mixtures 
In this section, interaction of TMS1 and TMS3, together with TMS6 was investigated 
for two reasons. (1) There is a hypothetical model of metal binding site within the MntH 
[112]. This model proposed formation of a binding pocket between four residues in TMS1 
and TMS3. (2) Modeling of Nramp homologs on the LeuT/SLC6 structure suggests that in 
the structure of full-length protein TMS1 and TMS6 could form a pair of discontinuous 
helices, each composed of an extended peptide chain interconnecting two shorter α–helices 
[60]. 
3.4.1 CD analysis 
The mixtures of segments were also studied under the same conditions as individual 
TMS. The spectra of the secondary structure of mixtures in buffer are shown in Fig. 3.1. 
The mixture of TMS 1+6 had comparable structure to TMS1 (Fig. 3.1, Table 2 in 
Appendix 1). TMS 1+3 mixture showed a dominantly random structure in aqueous 
solution, with some ordered structures (Fig. 3.1, Table 2 in Appendix 1).  In comparison to 
the spectra of single peptides TMS1, TMS3 and TMS6, there is no visible sign of 
interaction between TMS1 and TMS3 or TMS1 and TMS6 in aqueous buffer. Moreover, 
no interaction leading to formation of any stable heterodimeric species was observed in 
the RP-HPLC profile (See section 3.1.2, Fig. 3.7, Table 3.2).  
In TFE, the secondary structures of peptide mixtures were a combination of -helix 
and strand (Fig. 4 in Appendix 1). The helical content for TMS 1+3 is slightly higher 
than for TMS 1+6 (24% and 20%, respectively). Both mixtures showed typical α-helix 
double negative maxima at 222 nm and 208 nm and a positive maximum around 192 nm 
(Fig. 4 in Appendix 1). In SDS the secondary structure was very different for each mixture 
(Fig. 3.16). TMS 1+6 showed -helical structure at/above the CMC. At concentration 
below the CMC the spectrum is a combination of -helix and -strand with negative 
maximum at 222 nm, a shoulder at 208 nm and a positive maximum at 193 nm. The -
helical content increased with the increasing concentration of SDS in the sample from 23% 
(below CMC: 1 mM SDS) to 30% (at CMC: 8 mM SDS) and 32.5% (above CMC: 20 mM 
SDS). The strand content was decreasing with the growth of the -helical content. 
The spectral characteristics of TMS 1+3 were influenced by the conformation of TMS3 at 
different concentrations of SDS. The most -helicity in the mixture of TMS1 and TMS3 
was observed below CMC (-helix content ~ 42%). At CMC the -helicity dropped to 
62 
 
20% whereas above CMC the helicity increased to 35%. TMS 1+3 showed two negative 
maxima at 222 nm and 208 nm with positive maximum at 193 nm for all three spectra, but 
the intensity of elipticity was the weakest at CMC. TMS1 and TMS3 did not show any 
interaction at the CMC, slight interaction was observed for TMS1 and TMS6. 
The combination of all three segments together showed some interaction under these 
experimental conditions (Fig. 5 in Appendix 1). 
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Figure 3.16 CD spectra of peptide mixtures in SDS; TMS 1+3 (left) TMS 1+6 (right) 
Interaction of transmembrane segments was studied in lipid systems in order to 
determine the possible connection to the functional properties. The CD spectra of TMS 
mixtures normalized at 220 nm in different lipid systems are shown in Fig. 6 and Fig. 7 in 
Appendix 1, and the deconvolution analysis is shown in Table 2 in Appendix 1. The CD 
spectra of the mixtures of segments in DPhPC/DPhPG vesicles were compared with 
the calculated values. The calculated values were obtained from the addition of values for 
single segments of TMS1 and TMS3, TMS1 and TMS6 (Fig. 3.16). The change of spectra 
in DPhPC/DPhPG vesicles implies interaction between segments TMS1 and TMS3, and 
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between TMS1 and TMS6 as well. This interaction was even more emphasized in 
the presence on manganese ions (Fig. 3.17). Both TMS1 and TMS6 segments have one 
negatively charged residue and two positively charged ones, these positively charged 
termini may help the insertion and interaction in the lipid vesicles. In POPC/POPG vesicles 
TMS1 and TMS6 showed significant difference between the experimentally obtained and 
calculated spectra. On the other hand, in comparison to DPhPC/DPhPG vesicles, 
interaction between segments TMS1 and TMS3 in POPC/POPG was less pronounced 
(Fig. 8 in Appendix 1). The interaction between TMS1 and TMS3 in POPC/POPG was 
comparable to the interaction in POPE/POPG vesicles. No significant difference was 
observed in E. coli polar lipid extract for TMS1 and TMS3 or TMS 1 and TMS6 segments. 
The interaction of segments is dependent on the surrounding environment of 
the transmembrane segments. The interaction of segments was observed in membrane 
mimetic environment; on the other hand the interaction in lipid vesicles was strongly 
dependent on the composition of the vesicles. 
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Figure 3.17 Comparative spectra of experimental vs. calculated data for mixtures of segments TMS1, 
TMS3 and TMS6 in DPhPC/DPhPG vesicles, (A) in the absence and (B) in the presence of 2 mM MnCl2. 
Calculated data are normalized at 220 nm. 
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3.4.2 Electrophysiological studies using patch–clamp 
In contrast to the individual TMS, in case of TMS 1+3 under the same experimental 
conditions, channel activity was rarely observed (in 23% of trial), mostly two-state 
channels with very low conductance (maximum ~ 10 pS). The mixture of TMS 1+6 under 
the same experimental conditions showed no channel activity. The disability of peptide 
mixture to form stable channels contrary to individual peptides might be due to 
the interaction of TMS in DPhPC/DPhPG vesicles in the presence of manganese 
(Fig. 3.17). 
3.4.3 RP-HPLC analysis 
According to the HPLC chromatograms mixtures of TMS 1+3 and TMS 1+6 do not 
interact together to form a detectable stable species in aqueous environment. The retention 
times reveal that TMS1 was the least hydrophobic peptide segment (lowest retention time). 
The highest retention time and therefore the highest hydrophobicity was observed for 
TMS3 (Fig. 3.18). 
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Figure 3.18 HPLC data of peptides (A) TMS1 (B) TMS3 (C) TMS6 and (D) mixture of TMS 1+3+6 
A B 
C D 
TMS1 
TMS6 
 
23.373 ± 0.020 
38.422 ± 0.024 
24.648 ± 0.047 
TMS3 
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4. Discussion 
In order to obtain more information about individual transmembrane segments of E.coli 
MntH transporter (and consequently also about full-length protein), we studied secondary 
structure and interaction of synthetic peptides corresponding to the selected TMS in 
different environments (including buffer, detergent micelles and SUVs) using CD 
spectroscopy. Their functional properties were studied using patch clamp measurements.  
As demonstrated by the far-UV CD spectra, generally the peptide structures in lipid 
vesicles compared to buffer, changed from unordered to more ordered and in some cases 
helical conformations. This conformational change indicated the insertion of peptides into 
the lipid bilayer and their interaction with lipids. Alternatively, in 50% TFE the peptides 
were dominantly monomeric, thus TFE promoted the formation of independent helical 
conformations (Fig. 3.2, Fig. 3.6 and Fig. 13 in Appendix 3). In comparison the secondary 
structure of peptides in all studied lipid vesicles (Fig. 3.3, Fig. 3.8 and Fig. 3.12) implies 
that peptide interaction with lipid membranes can lead to partial association of 
transmembrane segments. This is clearly substantiated by switching of the ratio of 208/222 
from values more than 1 (in 50% TFE) to less than 1 (in lipid vesicles). The same reversal 
of negative maxima ratio has been previously observed in coiled-coil motifs and 
oligomerization of helical peptides in lipid membrane milieus [142]. The change of CD 
spectra in lipid vesicles therefore supports the change in conformation of peptides 
following their interaction with the lipid bilayers. The structural information obtained from 
CD spectroscopy experiments supports the results obtained in previous study investigating 
TMS3 of eukaryotic Nramp in lipid vesicles. The perturbation of TMS3 to lipid packing 
was pH dependent. Overall, the helical content for TMS3 was low for pH 7, but in PC 
lipids under acidic pH the peptide was predominantly helical. The folding of the peptide is 
dependent on composition of phospholipids  [110].  
The ability of TMS1, TMS3, TMS6 and TMS6-OH to form conducting channels shows 
that at least these peptides are able to fully cross the membrane under our experimental 
conditions. Full insertion of peptides in the lipid membranes could be partly induced by 
the membrane potential, missing during CD experiments. The ion conducting units of 
peptides ion channel could be formed by a helical bundle composed of several peptide 
molecules corresponding to the transmembrane segments of MntH. The possible 
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association of the peptide helices is also supported by the CD spectra of this peptide in 
lipid membranes exhibited in Fig. 3.3, Fig. 3.8 and Fig. 3.12). The pH dependence of 
TMS6 ability to form ion channels is correlated to the secondary structure alternation of 
the orthologous segment from rat Nramp2 induced by pH changes [109]. 
Even though single peptides TMS1, TMS3 and TMS6 were able to form stable ion 
channels at least in the presence of manganese ions, the TMS mixtures did not show strong 
channel activity. It is suggested that the interaction of peptides followed by 
the conformational change of the segment mixture prevents the mixture from either fully 
spanning the lipid bilayer or forming appropriate conducting units within the membrane 
(Fig. 3.17). TMS 1+6 mixture in DPhPC/DPhPG vesicles showed similar helicity to 
TMS1, higher than TMS6 itself but contrary to the individual TMS, this mixture was not 
able to form an active ion channel. However, the ability to form ion channels need not to 
be directly correlated with the helix-forming propensity of the peptides or their affinity for 
lipid membranes as shown for individual TMS of UCP2 [97]. The helicity of TMS1+3 was 
in-between the helicities of the single peptides, and the channels of very low conductance 
were observed only rarely. 
The ability of TMS3 to form Mn-dependent channels is quite interesting finding. TMS3 
in MntH is putatively taking part in metal binding [112]. It is highly probable that 
the conducting units are oligomers of the peptides and therefore the transport pathway is 
different from that of intact monomeric protein. It has been already found in other proteins, 
that some of their transmembrane parts are able to behave like channels [96,97] and even 
to retain partly the substrate specificity of their original protein. At present, it is not clear, 
how universal this phenomenon could be and whether it is connected to the evolution of 
membrane proteins. There is no direct proof of this phenomenon, since there are not many 
known 3D structures of transport proteins. Regarding the known variable stoichiometry of 
Nramp/MntH proteins, the fact that TMS3 is able to create ion channels in membrane 
might support the possibility of a multimeric functional form for these proteins. 
Even though the α-helicity in DPhPC/DPhPG vesicles for TMS6 is almost twice as 
high as for TMS6-OH, this difference has no significant influence on the ability of 
the peptide to form ion channels. Another interesting finding is the disability of H211R to 
form any channels. H211R attains the most helical conformation in DPhPC/DPhPG lipid 
vesicle milieus. Hence, the ability to form conducting channels is not directly related to α-
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helical content in the peptides. It seems improbable that the peptide interacts better with 
the lipid membranes just due to the positive charge of its Arg residue (the membranes 
contain PG headgroups and are negatively charged). Addition of the divalent cation like 
manganese, which should reduce the negative surface charge on the membrane surface, 
increased the helicity of peptides but did not influence the order of their helical contents. 
Interestingly, the lack of correlation between helical content and channel-forming ability 
was observed in [97] as well. 
The channel-forming properties of TMS6 further underline the importance of two 
conserved histidine residues for the full-length protein function. It has been previously 
reported that mutation of the homologous conserved histidine residues to Ala, Cys or Arg 
results in reduced or complete loss of function of Nramp2 in vivo [111]. Our findings at 
the level of individual TMS are in agreement with this study suggesting that His
267
 of 
the full–length Nramp2 plays an important role in the pH regulation of metal transport by 
this protein. The same authors suggest that protonation and/or deprotonation could favor 
conformational changes facilitating the transport function of Nramp2 [111]. Moreover, 
according to this study it seems unlikely that in full-length Nramp2, this pair of histidine 
residues could either bind metal ions directly or simply be part of a relay or channel 
enabling proton movement across the membrane [111]. 
Likewise, homologous His
211
 located within TMS6 of E. coli MntH was shown to 
regulate pH dependent metal uptake [60,63]. This residue was found to be accessible to 
solvent in full-length MntH, supporting a direct role of His
211
 protonation/deprotonation in 
transport cycle [60]. At the level of individual TMS, the mutation of His
211
 to Arg clearly 
prevented the peptide to form ion channels and even in the case of the mutation to Ala 
the stable channels were rarely formed. The channel activity of TMS6 suggests that His
211
 
protonation/deprotonation could rather induce conformational changes facilitating transport 
function in this transmembrane segment (see Chapter 3.3.2). 
Manganese ion (Mn
2+
), as one of the metal substrates of MntH protein, induced minor 
changes in the CD spectra, mostly causing increase in helicity. Interaction of TMS 1+3 and 
TMS 1+6 in lipid vesicles was emphasized in the presence of manganese ions. From 
the patch clamp data, the effect of Mn
2+
 on ion conductance with TMS1 and TMS6 is not 
clear. In contrast, obvious effects of manganese ions on ion conductance have been 
observed for TMS3 [140]. As supported by the CD data, manganese ions can directly 
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interact with the peptide and therefore affect the association/dissociation properties of 
peptide oligomers. On the other hand, manganese ions interact with the lipid headgroups 
and thus influence the properties of the membrane and, indirectly, the conformation of 
peptide channels - possibly the membrane insertion step.  
The selectivity of measured peptides TMS3 and TMS6-OH channels, with slight 
preference of cations (K
+
) over anions (Cl
-
), resembles the properties of yeast homolog 
Smf1p. Smf1p was reported to form an ion channel conducting monovalent cations (Na
+
, 
K
+
, Li
+
) [56]. However, protons do not seem to be among the specific substrates of 
the peptide channel. TMS3 has three negatively charged residues, but the sequence of 
TMS6-OH does not provide obvious reasons for preference of cations, as there is only one 
negative residue (glutamate near the N-terminus of the peptide), and the two protonated 
histidines (at pH 5.0) are located near the center of the transmembrane part. The negatively 
charged lipid headgroups (PG in our case) could be in both cases involved in the channel 
structure (toroidal model as it for some small peptides [143]). It cannot be excluded that 
the lipids could play a structural and/or functional role in the whole protein as well as it 
was shown for cardiolipin and ADP/ATP carrier [144]. 
The formation of ion channels in lipid membranes by a transmembrane segment of 
secondary active transporter can naturally provoke questions about the relevance and 
implications of such a finding for the full-length transport protein. Several studies 
demonstrated that the individual TMS of transmembrane ion channels of known 3D 
structure can assume membrane-integrated conformations almost identical with the overall 
conformation of full-length proteins [76,90,94] and form native-like interactions leading to 
formation of ion channels [74] showing functional properties comparable to the native 
proteins [60,97,145]. Furthermore, there is a growing evidence that ion channels and active 
transporters might have common features [105,106]. It has been suggested that at least 
some of the secondary active transporters could contain a channel inside their structure, 
either with a single-file of binding sites [104], or with multiple gates rather than a single 
gate [146]. In addition, proteins from the Nramp family show striking properties, which 
can be described in terms of channel-like models. Metal-independent proton transport and 
proton-independent metal transport were described under specific conditions [1,141]. 
A spontaneous recurrent mutation G185R converts Nramp2 functionally into a calcium 
channel [147]. Moreover, metal-dependent proton slip can be also interpreted in terms of 
a channel-like mechanism [107]. 
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5. Conclusion 
The main objective of this study was to study the secondary structure and interactions 
of synthetic peptides corresponding to three selected transmembrane segments of E. coli 
MntH in model membranes and to investigate their functional properties. From multitude 
of CD experiments in different environments including among others also model 
membranes of diverse lipid compositions and corresponding patch clamp experiments, we 
can draw several important conclusions. 
The individual synthetic peptides, corresponding to the three TMS, self-associate after 
the interaction with lipid vesicles. Moreover, all studied TMS are able to span 
the DPhPC/DPhPG membrane, since TMS6, TMS3 and TMS1 show ion channel activity. 
However, no direct correlation between the secondary structure of the TMS and functional 
properties was discovered. Furthermore, the properties of these slightly cation selective ion 
channels are to some extent analogical to the properties of full-length MntH protein: 
Manganese as physiological substrate of MntH is necessary for TMS3 channel formation. 
Manganese also modulate TMS6 channel function, the function of some TMS channels is 
pH dependent and His
211
 plays an important role in TMS6 channel- as well as full-length 
protein- function. Strikingly, although all transmembrane segments studied were able to 
form ion channels under certain experimental conditions, the TMS 1+3 or TMS 1+6 
mixtures under the same experimental conditions were not. 
Naturally, it is obvious that several interesting and fundamental questions arising from 
our results still wait to be answered: 
First of all, how many other TMS of E. coli MntH show ion channel activity? By 
analogy to UCP2 carrier containing only two channel forming TMS of total six [97], we 
can expect that the number of TMS with ion channel activity is limited. Hence, it can be 
suggested that channel forming TMS domains are restricted to the functionally important 
TMS of the membrane transport proteins. However, this hypothesis remains to be verified.  
Furthermore, it has been shown that selected TMS of E. coli MntH form cation 
selective channels, but further research should address the question to what extent this 
peptide-specific activity represents a functional aspect of full-length secondary-active 
transport protein. Regarding to certain similarity between ion-channels and transporter 
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[105] and especially to properties of Nramp/MntH, it should be certainly interesting to 
establish, whether specific structural parallels between those two exist.  
Last but not least, the structure of the TMS channels needs to be verified. Our study 
suggested the approximate number of helices forming an active channel. This number of 
monomers forming a channel should be confirmed. Moreover the possible interaction 
between the monomers and specific lipids should be studied. 
It is unfortunately evident that some of these questions cannot be answered without 
the knowledge of corresponding 3D structures. 
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Appendices 
Appendix 1: Additional CD spectra and deconvolution analysis of TMS1 
and peptide mixtures 
Table 1 Deconvolution analysis of TMS1 spectra in different environments 
  Secondary structure [%]  
  α−helix β−strand Turns Unordered 
buffer 7.0 35.5 22.5 35.0 
+ 2 mM MnCl2 7.2 35.8 23.1 33.9 
50% TFE 25.8 24.5 20.8 29.0 
+ 2 mM MnCl2 38.0 16.1 28.7 17.4 
1 mM SDS 23.7 31.9 16.3 28.1 
+ 2 mM MnCl2 25.7 29.5 17.8 27.1 
8 mM SDS 27.4 29.9 15.4 27.3 
+ 2 mM MnCl2 29.9 25.2 18.2 26.6 
20 mM SDS 27.6 28.8 16.5 27.1 
+ 2 mM MnCl2 30.4 24.6 18.7 26.3 
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Figure 1 CD spectra of TMS1 in POPC/POPG vesicles 
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Figure 2 CD spectra of TMS1 in E. coli polar lipid extract vesicles 
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Figure 3 CD spectra of TMS1 in POPE/POPG vesicles 
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Figure 4 CD spectra of the mixtures TMS 1+3 and TMS 1+6 in 50% TFE 
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Figure 5 CD spectra from experiment vs. calculated data from segments TMS1, TMS3 and TMS6 in SDS at 
CMC. Calculated data are normalized to 220 nm to the experimental spectra. 
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Figure 6 CD spectra of the mixture TMS 1+3 in all lipid systems. Spectra are normalize to 220 nm 
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Figure 7 CD spectra of the mixture TMS 1+6 in all lipid systems. Spectra are normalize to 220 nm 
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Figure 8 CD spectra from experiment vs. calculated data from segments TMS1, TMS3 and TMS6 in 
POPC/POPG vesicles. Calculated data are normalized to 220 nm to the experimental spectra. 
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Table 2 Deconvolution analysis of spectra of segment mixtures TMS 1+3 and TMS 1+6 in buffer and lipid 
vesicles 
    Secondary structure [%]  
    α−helix β−strand Turns Unordered 
buffer TMS 1+3 6.8 37.0 22.9 33.3 
 + 2 mM MnCl2 6.7 36.8 22.5 34.0 
 TMS 1+6 7.3 34.7 22.8 35.2 
 + 2 mM MnCl2 6.7 36.9 22.5 33.9 
E. coli polar extract TMS 1+3 12.1 36.5 22.9 28.5 
 + 2 mM MnCl2 13.2 32.4 23.3 31.1 
 TMS 1+6 12.6 32.2 23.7 31.5 
 + 2 mM MnCl2 10.0 30.8 23.7 35.5 
DPhPC/DPhPG TMS 1+3 13.6 33.5 21.7 31.2 
 + 2 mM MnCl2 10.4 35.5 22.4 31.8 
 TMS 1+6 18.4 33.6 19.1 29.0 
 + 2 mM MnCl2 14.9 30.3 24.5 30.2 
POPC/POPG TMS 1+3 9.8 35.1 23.2 31.8 
 + 2 mM MnCl2 9.3 35.4 23.1 32.3 
 TMS 1+6 9.1 34.1 22.4 34.5 
  + 2 mM MnCl2 10.5 34.7 22.9 31.9 
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Appendix 2: Additional CD spectra and deconvolution analysis of TMS3 
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Figure 9 CD spectra of TMS3 in lipid vesicles with metal ions: DPhPC/DPhPG (solid lines) and 
POPC/POPG (dashed lines) 
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Figure 10 CD spectra of TMS3 in E. coli polar lipid extract SUV with different metal ions 
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Figure 11 CD spectra of TMS3 in different temperatures: 25°C (dashed line) and 40°C (solid line) 
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Figure 12 CD spectra of TMS3 in POPE/POPG vesicles with metal ions 
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Table 3 Deconvolution analysis of TMS3 spectra in TFE and SDS  
  Secondary structure [%] 
  −helix −strand Turns Unordered 
3.5% TFE 6.7 39.8 22.4 31.3 
+ 2 mM MnCl2 9.7 36.7 24.7 28.9 
25% TFE 11.8 35.8 22.0 30.6 
+ 2 mM MnCl2 11.8 35.1 22.8 30.3 
50% TFE 27.2 25.0 20.0 27.8 
+ 2 mM MnCl2 29.9 24.7 18.3 27.1 
1 mM SDS 51.5 9.3 17.5 21.8 
+ 2 mM MnCl2 50.3 11.7 15.7 22.4 
8 mM SDS 52.0 12.9 14.2 20.9 
+ 2 mM MnCl2 50.2 12.8 15.7 21.3 
20 mM SDS 41.1 17.6 16.6 24.7 
+ 2 mM MnCl2 37.2 21.1 15.1 26.5 
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Appendix 3: Additional CD spectra and deconvolution analysis of TMS6 
peptides 
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Figure 13 CD spectra of TMS6 peptides in 50 % TFE. Solid lines show spectra without manganese and 
dashed lines show spectra in the presence of 2 mM MnCl2. The spectra represent the average of two 
independent experiments. 
Table 4 Deconvolution analysis of TMS6 peptides spectra in 50% TFE 
  Secondary structure [%] 
  α−helix β−strand Turns Unordered 
TMS6-OH 41.2 16.6 17.3 24.9 
+ 2 mM MnCl2 46.4 15.0 15.8 22.9 
TMS6 46.3 13.6 15.8 24.3 
+ 2 mM MnCl2 40.6 17.5 15.8 26.2 
H211A 51.1 12.0 13.9 23.1 
+ 2 mM MnCl2 55.6 3.7 16.7 24.1 
H211R 52.7 12.2 13.2 21.9 
+ 2 mM MnCl2 56.9 5.6 15.3 22.2 
 
93 
 
190 200 210 220 230 240 250
-20000
-10000
0
10000
20000
30000
40000
50000

 
[d
e
g
.c
m
2
.d
m
o
l-1
]
 [nm]
  TMS6-OH
  H211A
  H211R
200 210 220 230 240 250
 [nm]
200 210 220 230 240 250 260
 [nm]  
Figure 14 CD spectra of TMS6-OH and mutants in different concentrations of SDS 
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Figure 15 CD spectra of TMS6 peptides in POPC/POPG vesicles 
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Table 5 Deconvolution analysis of TMS6 peptides spectra in SDS 
    Secondary structure [%]  
    α−helix β−strand Turns Unordered 
1 mM SDS TMS6-OH 18.3 38.2 15.2 28.2 
 + 2 mM MnCl2 22.7 31.7 18.0 27.7 
 H211A 29.5 30.1 12.7 27.8 
 + 2 mM MnCl2 31.6 26.5 16.3 25.6 
 H211R 37.7 23.7 14.6 24.0 
  + 2 mM MnCl2 46.9 17.8 13.6 21.7 
8 mM SDS TMS6-OH 22.2 32.8 16.9 28.1 
 + 2 mM MnCl2 31.7 24.2 17.7 26.5 
 H211A 54.4 9.5 15.0 21.1 
 + 2 mM MnCl2 53.0 9.4 14.9 22.6 
 H211R 50.8 13.9 13.7 21.7 
  + 2 mM MnCl2 54.9 5.0 19.6 20.5 
20 mM SDS TMS6-OH 31.3 25.6 16.9 26.2 
 + 2 mM MnCl2 32.2 24.8 17.2 25.9 
 H211A 44.2 18.4 14.5 22.8 
 + 2 mM MnCl2 56.3 10.7 13.3 19.7 
 H211R 50.4 14.9 14.3 20.4 
  + 2 mM MnCl2 50.0 14.5 14.5 21.1 
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Figure 16 CD spectra of TMS6 peptides in E. coli polar lipid extract 
Table 6 Deconvolution analysis of TMS6 peptides spectra in E. coli polar lipid extract 
  Secondary structure [%] 
  α−helix β−strand Turns Unordered 
TMS6-OH 7.9 34.4 22.9 32.7 
+ 2 mM MnCl2 10.4 29.9 24.2 35.5 
+ 2 mM CdCl2 12.2 18.7 28.1 31.0 
TMS6 16.3 28.1 25.2 30.5 
+ 2 mM MnCl2 13.1 29.4 24.8 32.6 
H211A 24.0 30.2 17.7 28.0 
+ 2 mM MnCl2 18.5 26.1 22.9 32.5 
+ 2 mM CdCl2 8.7 36.2 24.6 30.5 
H211R 13.3 31.6 21.1 32.0 
+ 2 mM MnCl2 11.4 32.3 23.8 32.5 
+ 2 mM CdCl2 10.5 31.7 25.3 32.6 
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